FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Bandeira, AC
   Gois, LL
   Campos, GS
   Sardi, S
   Yssel, H
   Vieillard, V
   Autran, B
   Grassi, MFR
AF Bandeira, Antonio Carlos
   Gois, Luana Leandro
   Campos, Gubio Soares
   Sardi, Silvia
   Yssel, Hans
   Vieillard, Vincent
   Autran, Brigitte
   Rios Grassi, Maria Fernanda
TI Clinical and laboratory findings of acute Zika virus infection in
   patients from Salvador during the first Brazilian epidemic
SO BRAZILIAN JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE Zika virus; Clinical presentation; Polymerase chain reaction; Bahia
ID DENGUE VIRUSES; OUTBREAK; CHIKUNGUNYA; URINE; RNA
AB Several major epidemics of Zika fever, caused by the ZIKA virus (ZIKV), have emerged in Brazil since early 2015, eventually spreading to other countries on the South American continent. The present study describes the clinical manifestations and laboratory findings of patients with confirmed acute ZIKV infection during the first epidemic that occurred in Salvador, Brazil. All included patients were seen at the emergency room of a private tertiary hospital located in Salvador, Brazil from 2015 through 2017. Patients were considered eligible if signs of systemic viral febrile disease were present. All individuals were tested for ZIKV and Chikungunya infection using PCR, while rapid test was used to detect Dengue virus antibodies or, alternatively, the NS1 antigen. A diagnosis of acute ZIKV infection was confirmed in 78/434 (18%) individuals with systemic viral febrile illness. Positivity was mainly observed in blood, followed by saliva and urine. Coinfection with Chikungunya and/or Dengue virus was detected in 5% of the ZIKV-infected patients. The most frequent clinical findings were myalgia, arthralgia and low-grade fever. Laboratory analysis demonstrated normal levels of hematocrit, platelets and liver enzymes. In summary, in acute settings where molecular testing remains unavailable, clinicians face difficulties to confirm the diagnosis of ZIKV infection, as they rely only on clinical examinations and conventional laboratory tests. (C) 2020 Sociedade Brasileira de Infectologia. Published by Elsevier Espana, S.L.U.
C1 [Bandeira, Antonio Carlos] UniFTC, Fac Med, Salvador, BA, Brazil.
   [Bandeira, Antonio Carlos; Gois, Luana Leandro; Rios Grassi, Maria Fernanda] Fundacao Oswaldo Cruz, Inst Goncalo Moniz, FIOCRUZ, Salvador, BA, Brazil.
   [Gois, Luana Leandro; Rios Grassi, Maria Fernanda] Escola Bahiana Med & Saude Publ, Salvador, BA, Brazil.
   [Campos, Gubio Soares; Sardi, Silvia] Univ Fed Bahia, Inst Ciencias Saude, Salvador, BA, Brazil.
   [Yssel, Hans; Vieillard, Vincent; Autran, Brigitte] Univ Pierre Marie Curie, Sorbonne Univ, Ctr Immunol & Malad Infect, Paris, France.
RP Bandeira, AC (corresponding author), UniFTC, Fac Med, Salvador, BA, Brazil.; Bandeira, AC (corresponding author), Fundacao Oswaldo Cruz, Inst Goncalo Moniz, FIOCRUZ, Salvador, BA, Brazil.
EM antoniobandeira@gmail.com
OI BANDEIRA, ANTONIO/0000-0002-7273-8376; Grassi, Maria
   Fernanda/0000-0002-7356-5569; Vieillard, Vincent/0000-0002-9362-3922;
   Gois, Luana Leandro/0000-0002-7538-3558
FU European Union's Horizon 2020 Research and Innovation Programme under
   ZIK Alliance Grant [734548]
FX This work was supported by the European Union's Horizon 2020 Research
   and Innovation Programme under ZIK Alliance Grant Agreement no. 734548.
CR Azeredo Elzinandes Leal, 2018, PLoS Curr, V10, DOI 10.1371/currents.outbreaks.0bf6aeb4d30824de63c4d5d745b217f5
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Edwards CJ, 2007, J CLIN VIROL, V39, P271, DOI 10.1016/j.jcv.2007.05.008
   European Centre for Disease Prevention and Control, 2014, RAP RISK ASS ZIK VIR
   Gyurech D, 2016, SWISS MED WKLY, V146, DOI 10.4414/smw.2016.14296
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Obonyo M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198556
   Oehler E, 2015, EUROSURVEILLANCE, V20, P13, DOI 10.2807/1560-7917.ES.2015.20.48.30079
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Oliveira WK de, 2015, B EPIDEMIOLOGICO SVS, V46, P1
   Pessoa R, 2016, EUROSURVEILLANCE, P21, DOI DOI 10.2807/1560-7917.ES.7016.71.30.30302
   Quinn EJ, 2018, TROP MED INFECT DIS, V3, DOI 10.3390/tropicalmed3010006
   Rossini G, 2017, J INFECTION, V75, P242, DOI 10.1016/j.jinf.2017.05.021
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Stewart-Ibarra AM, 2018, AM J TROP MED HYG, V98, P1444, DOI 10.4269/ajtmh.17-0762
   Tozetto-Mendoza TR, 2019, REV INST MED TROP SP, V61, DOI [10.1590/S1678-9946201961019, 10.1590/s1678-9946201961019]
   Yan G, 2018, EMERG INFECT DIS, V24, P1565, DOI 10.3201/eid2408.171883
NR 26
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER BRAZIL
PI RIO DE JANEIRO
PA R SETE SETEMBRO, 111-16, RIO DE JANEIRO, RJ 20050-006, BRAZIL
SN 1413-8670
EI 1678-4391
J9 BRAZ J INFECT DIS
JI Braz. J. Infect. Dis.
PD SEP-OCT
PY 2020
VL 24
IS 5
BP 405
EP 411
DI 10.1016/j.bjid.2020.08.005
PG 7
WC Infectious Diseases
SC Infectious Diseases
GA OH5ID
UT WOS:000582615500005
PM 32941805
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Campos, GS
   Carvalho, RH
   Bandeira, AC
   Reboredo-Oliveira, L
   Costa, RD
   Figueiredo, CA
   Sardi, SI
AF Campos, Gubio Soares
   Carvalho, Rejane Hughes
   Bandeira, Antonio Carlos
   Reboredo-Oliveira, Luciana
   Costa, Ryan dos Santos
   Figueiredo, Camila Alexandrina
   Sardi, Silvia Ines
TI New Challenge for Zika Virus Infection: Human Reservoirs?
SO VIRAL IMMUNOLOGY
LA English
DT Article
DE Zika virus; persistence; viremia; immune complacency
ID PERSISTENCE
AB Zika virus (ZIKV) is considered to cause an acute self-limited infection in adults, and microcephaly in fetus. Presence of the virus for long periods has been detected in body fluids; however, persistent viremia in serum for more than 1 year has not yet been reported. We have investigated persistence of ZIKV in serum samples of 77 subjects who were infected by the virus between 18 months and 3 years before the start of this study. The subjects included children with microcephaly and their parents. Serum samples were subjected to routine RT-qPCR assay for ZIKV, Chikungunya virus, and Dengue virus. From the 77 subjects, five showed positive for the presence of ZIKV particles by RT-qPCR, including four members of the same family. Viral isolation in Vero cells and C6/36 cells confirmed the result and showed the viral particles were active. We have detected viremia in healthy carriers up to 3 years after symptom onset. Humans acting as potential viral reservoirs have major implication for the current understanding of ZIKV infection.
C1 [Campos, Gubio Soares; Carvalho, Rejane Hughes; Sardi, Silvia Ines] Univ Fed Bahia, Hlth Sci Inst, Virol Lab, Av Reitor Miguel Calmon S-N, BR-40110100 Salvador, BA, Brazil.
   [Bandeira, Antonio Carlos] Hosp Inst Couto Maia, Salvador, BA, Brazil.
   [Bandeira, Antonio Carlos] Hosp Alianca, Salvador, BA, Brazil.
   [Reboredo-Oliveira, Luciana; Costa, Ryan dos Santos; Figueiredo, Camila Alexandrina] Univ Fed Bahia, Hlth Sci Inst, Salvador, BA, Brazil.
RP Carvalho, RH (corresponding author), Univ Fed Bahia, Hlth Sci Inst, Virol Lab, Av Reitor Miguel Calmon S-N, BR-40110100 Salvador, BA, Brazil.
EM hughescv@gmail.com
RI Costa, Ryan S/G-4294-2016
OI Costa, Ryan S/0000-0003-3075-0729
FU  [88887-116628/2016];  [FINEP-FNDCT 011/2016-ZIKA]
FX This research was funded by the Zika Fast TrackCAPES project no.
   88887-116628/2016 and FINEP-FNDCT 011/2016-ZIKA.
CR Aid M, 2017, CELL, V169, P610, DOI 10.1016/j.cell.2017.04.008
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Brett DLB, 2013, FIELDS VIROLOGY, VI, P735
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Colt S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005528
   Duarte G, 2017, REV BRAS GINECOL OBS, V39, P235, DOI 10.1055/s-0037-1603450
   Garcia MN, 2015, MICROBES INFECT, V17, P163, DOI 10.1016/j.micinf.2014.12.003
   Hansen TR, 2010, AM J REPROD IMMUNOL, V64, P295, DOI 10.1111/j.1600-0897.2010.00904.x
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Kerr JR, 2005, J VET MED B, V52, P335, DOI 10.1111/j.1439-0450.2005.00859.x
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Mlera L, 2014, PATHOG DIS, V71, P135, DOI 10.1111/2049-632X.12178
   Moorman JP, 2001, ARCH IMMUNOL THER EX, V49, P189
   Murray KO, 2013, AM J TROP MED HYG, V89, P996, DOI 10.4269/ajtmh.13-0232
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Pomar L, 2019, PRENATAL DIAG, V39, P420, DOI 10.1002/pd.5446
   Pomar L, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k4431
   Sanchez-Montalva A, 2018, TROP MED INT HEALTH, V23, P92, DOI 10.1111/tmi.13019
   SHARMA S, 1991, CLIN EXP IMMUNOL, V85, P85, DOI 10.1111/j.1365-2249.1991.tb05687.x
   Tsuboi T, 2011, RES VET SCI, V90, P174, DOI 10.1016/j.rvsc.2010.04.024
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
NR 22
TC 0
Z9 0
U1 1
U2 2
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 0882-8245
EI 1557-8976
J9 VIRAL IMMUNOL
JI Viral Immunol.
PD JUL 1
PY 2020
VL 33
IS 6
BP 489
EP 492
DI 10.1089/vim.2019.0187
EA APR 2020
PG 4
WC Immunology; Virology
SC Immunology; Virology
GA MQ6BC
UT WOS:000527805900001
PM 32311307
DA 2020-12-01
ER

PT S
AU Cumano, A
   Berthault, C
   Ramond, C
   Petit, M
   Golub, R
   Bandeira, A
   Pereira, P
AF Cumano, Ana
   Berthault, Claire
   Ramond, Cyrille
   Petit, Maxime
   Golub, Rachel
   Bandeira, Antonio
   Pereira, Pablo
BE Yokoyama, WM
TI New Molecular Insights into Immune Cell Development
SO ANNUAL REVIEW OF IMMUNOLOGY, VOL 37, 2019
SE Annual Review of Immunology
LA English
DT Review; Book Chapter
DE lymphoid progenitors; lineage commitment; innate lymphoid cells; fetal
   liver; thymus-settling progenitors; transcriptional signatures
ID HEMATOPOIETIC STEM-CELLS; COMMON LYMPHOID PROGENITORS; TISSUE-INDUCER
   CELL; ROR-GAMMA-T; B-CELL; RECEPTOR EXPRESSION; UP-REGULATION;
   BONE-MARROW; YOLK-SAC; TRANSCRIPTIONAL CONTROL
AB During development innate lymphoid cells and specialized lymphocyte subsets colonize peripheral tissues, where they contribute to organogenesis and later constitute the first line of protection while maintaining tissue homeostasis. A few of these subsets are produced only during embryonic development and remain in the tissues throughout life. They are generated through a unique developmental program initiated in lympho-myeloid-primed progenitors, which lose myeloid and B cell potential. They either differentiate into innate lymphoid cells or migrate to the thymus to give rise to embryonic T cell receptor-invariant T cells. At later developmental stages, adaptive T lymphocytes are derived from lympho-myeloid progenitors that colonize the thymus, while lymphoid progenitors become specialized in the production of B cells. This sequence of events highlights the requirement for stratification in the establishment of immune functions that determine efficient seeding of peripheral tissues by a limited number of cells.
C1 [Cumano, Ana; Berthault, Claire; Ramond, Cyrille; Petit, Maxime; Golub, Rachel; Bandeira, Antonio; Pereira, Pablo] Inst Pasteur, INSERM, U1223, Unite Lymphopoiese,Dept Immunol, F-75724 Paris 15, France.
   [Cumano, Ana; Berthault, Claire; Petit, Maxime; Golub, Rachel; Bandeira, Antonio; Pereira, Pablo] Univ Paris Diderot, Cellule Pasteur, Sorbonne Paris Cite, F-75015 Paris, France.
RP Cumano, A (corresponding author), Inst Pasteur, INSERM, U1223, Unite Lymphopoiese,Dept Immunol, F-75724 Paris 15, France.; Cumano, A (corresponding author), Univ Paris Diderot, Cellule Pasteur, Sorbonne Paris Cite, F-75015 Paris, France.
EM ana.cumano@pasteur.fr; claire.berthault@inserm.fr;
   pablo.pereira-esteva@pasteur.fr
RI ; GOLUB, rachel/M-7188-2014
OI Cumano, Ana/0000-0002-4578-959X; GOLUB, rachel/0000-0002-2306-5363;
   Pereira, Pablo/0000-0003-1784-2776; Bandeira Ferreira,
   Antonio/0000-0002-8054-8716
CR Abramson J, 2017, ANNU REV IMMUNOL, V35, P85, DOI 10.1146/annurev-immunol-051116-052320
   Adolfsson J, 2001, IMMUNITY, V15, P659, DOI 10.1016/S1074-7613(01)00220-5
   Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013
   Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599
   Aliahmad P, 2010, NAT IMMUNOL, V11, P945, DOI 10.1038/ni.1930
   ALLISON JP, 1991, ANNU REV IMMUNOL, V9, P679, DOI 10.1146/annurev.iy.09.040191.003335
   Allman D, 2003, NAT IMMUNOL, V4, P168, DOI 10.1038/ni878
   Bain G, 1997, IMMUNITY, V6, P145, DOI 10.1016/S1074-7613(00)80421-5
   Bando JK, 2015, NAT IMMUNOL, V16, P153, DOI 10.1038/ni.3057
   Barros RD, 2016, CELL, V167, P203, DOI 10.1016/j.cell.2016.08.030
   Beaudin AE, 2016, CELL STEM CELL, V19, P768, DOI 10.1016/j.stem.2016.08.013
   Bell JJ, 2008, NATURE, V452, P764, DOI 10.1038/nature06840
   Berthault C, 2017, NAT IMMUNOL, V18, P1139, DOI 10.1038/ni.3820
   Bertrand JY, 2005, BLOOD, V106, P3004, DOI 10.1182/blood-2005-02-0461
   Bertrand JY, 2005, P NATL ACAD SCI USA, V102, P134, DOI 10.1073/pnas.0402270102
   Bhandoola A, 2007, IMMUNITY, V26, P678, DOI 10.1016/j.immuni.2007.05.009
   Boiers C, 2013, CELL STEM CELL, V13, P535, DOI 10.1016/j.stem.2013.08.012
   Boyden LM, 2008, NAT GENET, V40, P656, DOI 10.1038/ng.108
   Busslinger M, 2004, ANNU REV IMMUNOL, V22, P55, DOI 10.1146/annurev.immunol.22.012703.104807
   Caprioli A, 2001, DEV BIOL, V238, P64, DOI 10.1006/dbio.2001.0362
   Carlyle JR, 1998, IMMUNITY, V9, P187, DOI 10.1016/S1074-7613(00)80601-9
   Carvalho TL, 2001, J EXP MED, V194, P1141, DOI 10.1084/jem.194.8.1141
   Ceredig R, 2007, EUR J IMMUNOL, V37, P830, DOI 10.1002/eji.200636728
   Chea S, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf2223
   Chea S, 2016, CELL REP, V14, P1500, DOI 10.1016/j.celrep.2016.01.015
   Cherrier DE, 2018, IMMUNITY, V48, P1091, DOI 10.1016/j.immuni.2018.05.010
   Cherrier M, 2012, J EXP MED, V209, P729, DOI 10.1084/jem.20111594
   COLTEY M, 1987, CELL DIFFER DEV, V22, P71, DOI 10.1016/0045-6039(87)90414-3
   Constantinides MG, 2014, NATURE, V508, P397, DOI 10.1038/nature13047
   Cumano A, 1996, CELL, V86, P907, DOI 10.1016/S0092-8674(00)80166-X
   Cumano A, 2001, IMMUNITY, V15, P477, DOI 10.1016/S1074-7613(01)00190-X
   Cumano A, 2007, ANNU REV IMMUNOL, V25, P745, DOI 10.1146/annurev.immunol.25.022106.141538
   de Bruijn MFTR, 2000, EMBO J, V19, P2465, DOI 10.1093/emboj/19.11.2465
   De Obaldia ME, 2015, ANNU REV IMMUNOL, V33, P607, DOI 10.1146/annurev-immunol-032414-112032
   de Sousa AP, 2012, J IMMUNOL, V189, P3822, DOI 10.4049/jimmunol.1103723
   Desanti GE, 2011, J IMMUNOL, V186, P5227, DOI 10.4049/jimmunol.1002686
   Dias S, 2005, J EXP MED, V201, P971, DOI 10.1084/jem.20042393
   Douagi I, 2002, SEMIN IMMUNOL, V14, P361, DOI 10.1016/S1044532302000702
   Douagi I, 2002, BLOOD, V99, P463, DOI 10.1182/blood.V99.2.463
   Duber S, 2009, BLOOD, V114, P4960, DOI 10.1182/blood-2009-04-218156
   Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022
   Ehrlich LIR, 2011, BLOOD, V117, P2618, DOI 10.1182/blood-2010-05-287102
   Ferrell JE, 2012, CURR BIOL, V22, pR458, DOI 10.1016/j.cub.2012.03.045
   Gekas C, 2005, DEV CELL, V8, P365, DOI 10.1016/j.devcel.2004.12.016
   Godin I, 2002, NAT REV IMMUNOL, V2, P593, DOI 10.1038/nri857
   Haas JD, 2012, IMMUNITY, V37, P48, DOI 10.1016/j.immuni.2012.06.003
   HAYAKAWA K, 1985, J EXP MED, V161, P1554, DOI 10.1084/jem.161.6.1554
   Herzenberg LA, 2000, IMMUNOL REV, V175, P9, DOI 10.1034/j.1600-065X.2000.017520.x
   Hofer T, 2016, ANNU REV IMMUNOL, V34, P449, DOI 10.1146/annurev-immunol-032414-112019
   Hoppe PS, 2016, NATURE, V535, P299, DOI 10.1038/nature18320
   Igarashi H, 2001, P NATL ACAD SCI USA, V98, P15131, DOI 10.1073/pnas.011513098
   Ikawa T, 2006, J EXP MED, V203, P1329, DOI 10.1084/jem.20060268
   IKUTA K, 1990, CELL, V62, P863, DOI 10.1016/0092-8674(90)90262-D
   Inlay MA, 2009, GENE DEV, V23, P2376, DOI 10.1101/gad.1836009
   Ishizuka IE, 2016, NAT IMMUNOL, V17, P269, DOI 10.1038/ni.3344
   Jassinskaja M, 2017, CELL REP, V21, P3285, DOI 10.1016/j.celrep.2017.11.070
   JOTEREAU FV, 1982, J IMMUNOL, V129, P1869
   Karsunky H, 2008, BLOOD, V111, P5562, DOI 10.1182/blood-2007-11-126219
   Katsura Y, 2002, NAT REV IMMUNOL, V2, P127, DOI 10.1038/nri721
   Kawamoto H, 2000, IMMUNITY, V12, P441, DOI 10.1016/S1074-7613(00)80196-X
   Kieusseian A, 2012, DEVELOPMENT, V139, P3521, DOI 10.1242/dev.079210
   Kikuchi K, 2005, J EXP MED, V201, P1197, DOI 10.1084/jem.20050158
   Klose CSN, 2014, CELL, V157, P340, DOI 10.1016/j.cell.2014.03.030
   Koch U, 2008, J EXP MED, V205, P2515, DOI 10.1084/jem.20080829
   Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5
   Kristiansen TA, 2016, IMMUNITY, V45, P346, DOI 10.1016/j.immuni.2016.07.014
   Lai AY, 2008, SEMIN IMMUNOL, V20, P207, DOI 10.1016/j.smim.2008.05.002
   Lam KP, 1999, J EXP MED, V190, P471, DOI 10.1084/jem.190.4.471
   Lee DM, 1996, IMMUNOGENETICS, V44, P108
   LIN HH, 1995, NATURE, V376, P263, DOI 10.1038/376263a0
   Liu K, 2010, IMMUNOL REV, V234, P45, DOI 10.1111/j.0105-2896.2009.00879.x
   Luc S, 2012, NAT IMMUNOL, V13, P412, DOI 10.1038/ni.2255
   Luis TC, 2016, NAT IMMUNOL, V17, P1424, DOI 10.1038/ni.3576
   MACKAREHTSCHIAN K, 1995, IMMUNITY, V3, P147, DOI 10.1016/1074-7613(95)90167-1
   Malin S, 2010, NAT IMMUNOL, V11, P171, DOI 10.1038/ni.1827
   Mansson R, 2007, IMMUNITY, V26, P407, DOI 10.1016/j.immuni.2007.02.013
   Mansson R, 2010, BLOOD, V115, P2601, DOI 10.1182/blood-2009-08-236398
   Masuda K, 2005, EMBO J, V24, P4052, DOI 10.1038/sj.emboj.7600878
   Mebius RE, 1996, P NATL ACAD SCI USA, V93, P11019, DOI 10.1073/pnas.93.20.11019
   Mebius RE, 2001, J IMMUNOL, V166, P6593, DOI 10.4049/jimmunol.166.11.6593
   Medvinsky A, 1996, CELL, V86, P897, DOI 10.1016/S0092-8674(00)80165-8
   Mielke LA, 2013, J IMMUNOL, V191, P4383, DOI 10.4049/jimmunol.1301228
   Miyamoto T, 2002, DEV CELL, V3, P137, DOI 10.1016/S1534-5807(02)00201-0
   Montecino-Rodriguez E, 2016, IMMUNITY, V45, P527, DOI 10.1016/j.immuni.2016.07.012
   MORRISON SJ, 1995, P NATL ACAD SCI USA, V92, P10302, DOI 10.1073/pnas.92.22.10302
   MULLER AM, 1994, IMMUNITY, V1, P291, DOI 10.1016/1074-7613(94)90081-7
   NOGUCHI M, 1993, SCIENCE, V262, P1877, DOI 10.1126/science.8266077
   Nutt SL, 1999, NATURE, V401, P556
   Passegue E, 2005, J EXP MED, V202, P1599, DOI 10.1084/jem.20050967
   Perdiguero EG, 2015, NATURE, V518, P547, DOI 10.1038/nature13989
   Pereira P, 2012, J IMMUNOL, V188, P1600, DOI 10.4049/jimmunol.1102531
   Perry SS, 2004, BLOOD, V103, P2990, DOI 10.1182/blood-2003-09-3030
   Porritt HE, 2004, IMMUNITY, V20, P735, DOI 10.1016/j.immuni.2004.05.004
   Possot C, 2011, NAT IMMUNOL, V12, P949, DOI 10.1038/ni.2105
   Ramond C, 2014, NAT IMMUNOL, V15, P27, DOI 10.1038/ni.2782
   Rieger MA, 2009, SCIENCE, V325, P217, DOI 10.1126/science.1171461
   Roberts NA, 2012, IMMUNITY, V36, P427, DOI 10.1016/j.immuni.2012.01.016
   RODEWALD HR, 1994, EMBO J, V13, P4229, DOI 10.1002/j.1460-2075.1994.tb06743.x
   Rodewald HR, 1997, IMMUNITY, V6, P265, DOI 10.1016/S1074-7613(00)80329-5
   Rothenberg EV, 2008, NAT REV IMMUNOL, V8, P9, DOI 10.1038/nri2232
   Rothenberg EV, 2014, ANNU REV IMMUNOL, V32, P283, DOI 10.1146/annurev-immunol-032712-100024
   Samokhvalov IM, 2007, NATURE, V446, P1056, DOI 10.1038/nature05725
   Sawai CM, 2016, IMMUNITY, V45, P597, DOI 10.1016/j.immuni.2016.08.007
   Schlenner SM, 2010, IMMUNITY, V32, P426, DOI 10.1016/j.immuni.2010.03.005
   Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0
   Schwarz BA, 2004, NAT IMMUNOL, V5, P953, DOI 10.1038/ni1101
   Seillet C, 2016, CELL REP, V17, P436, DOI 10.1016/j.celrep.2016.09.025
   Serafini N, 2014, J EXP MED, V211, P199, DOI 10.1084/jem.20131038
   Sitnicka E, 2002, IMMUNITY, V17, P463, DOI 10.1016/S1074-7613(02)00419-3
   Sitnicka E, 2003, J EXP MED, V198, P1495, DOI 10.1084/jem.20031152
   Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365
   Taoudi S, 2008, CELL STEM CELL, V3, P99, DOI 10.1016/j.stem.2008.06.004
   Teschendorff AE, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15599
   Traver D, 2000, SCIENCE, V290, P2152, DOI 10.1126/science.290.5499.2152
   Tsapogas P, 2011, BLOOD, V118, P1283, DOI 10.1182/blood-2011-01-332189
   Turchinovich G, 2011, IMMUNITY, V35, P59, DOI 10.1016/j.immuni.2011.04.018
   Turner AM, 1996, BLOOD, V88, P3383, DOI 10.1182/blood.V88.9.3383.bloodjournal8893383
   Uehara S, 2002, J IMMUNOL, V168, P2811, DOI 10.4049/jimmunol.168.6.2811
   von Muenchow L, 2016, P NATL ACAD SCI USA, V113, pE8122, DOI 10.1073/pnas.1613316113
   Vosshenrich CAJ, 2004, P NATL ACAD SCI USA, V101, P11070, DOI 10.1073/pnas.0402919101
   Wada H, 2008, NATURE, V452, P768, DOI 10.1038/nature06839
   Weber BN, 2011, NATURE, V476, P63, DOI 10.1038/nature10279
   Weissman IL, 2001, ANNU REV CELL DEV BI, V17, P387, DOI 10.1146/annurev.cellbio.17.1.387
   Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048
   Yagi RJ, 2014, IMMUNITY, V40, P378, DOI 10.1016/j.immuni.2014.01.012
   Yang Q, 2015, NAT IMMUNOL, V16, P1044, DOI 10.1038/ni.3248
   Yoder MC, 1997, IMMUNITY, V7, P335, DOI 10.1016/S1074-7613(00)80355-6
   Yokota T, 2003, IMMUNITY, V19, P365, DOI 10.1016/S1074-7613(03)00231-0
   Yokota T, 2006, DEVELOPMENT, V133, P2041, DOI 10.1242/dev.02349
   Yokota Y, 1999, NATURE, V397, P702, DOI 10.1038/17812
   Yoshida H, 1999, INT IMMUNOL, V11, P643, DOI 10.1093/intimm/11.5.643
   Yoshida H, 2001, J IMMUNOL, V167, P2511, DOI 10.4049/jimmunol.167.5.2511
   Zook EC, 2016, NAT IMMUNOL, V17, P775, DOI 10.1038/ni.3481
NR 133
TC 4
Z9 4
U1 1
U2 9
PU ANNUAL REVIEWS
PI PALO ALTO
PA 4139 EL CAMINO WAY, PO BOX 10139, PALO ALTO, CA 94303-0897 USA
SN 0732-0582
BN 978-0-8243-3039-2
J9 ANNU REV IMMUNOL
JI Annu. Rev. Immunol.
PY 2019
VL 37
BP 497
EP 519
DI 10.1146/annurev-immunol-042718-041319
PG 23
WC Immunology
SC Immunology
GA BN4RN
UT WOS:000482702900020
PM 31026413
DA 2020-12-01
ER

PT J
AU Rocha, VFD
   de Oliveira, AHP
   Bandeira, AC
   Sardi, SI
   Garcia, RF
   Magalhaes, SD
   Sampaio, CA
   Soares, GC
AF Diniz Rocha, Veronica Franca
   Principe de Oliveira, Adriano Hasler
   Bandeira, Antonio Carlos
   Sardi, Silvia Ines
   Garcia, Rodrigo Freaza
   Magalhaes, Samuel de Araujo
   Sampaio, Camila Alves
   Soares, Gubio Campos
TI Chikungunya Virus Infection Associated with Encephalitis and Anterior
   Uveitis
SO OCULAR IMMUNOLOGY AND INFLAMMATION
LA English
DT Letter
DE Anterior uveitis; Chikungunya uveitis; CHIKV encephalitis; CHIKV
   uveitis; cotton wool spots
AB Chikungunya virus (CHIKV) is an RNA virus transmitted by Aedes mosquitoes. The clinical manifestations include fever, arthralgia, rash, and other atypical clinical findings including ocular lesions. We report the case of a 57-year-old man with meningoencephalitis and anterior uveitis due to CHIKV. The patient had developed bilateral anterior uveitis with iris atrophy and a cotton wool spot on the left eye, and his serum, urine, saliva, and cerebrospinal fluid were positive for CHIKV by RT-PCR. The spectrum of the ophthalmologic manifestations and its pathophysiology in cases of CHIKV infections needs to be better understood. Additional studies examining the ocular lesions caused by CHIKV could improve the therapeutic goals of reducing the morbidity and sequels.
C1 [Diniz Rocha, Veronica Franca; Garcia, Rodrigo Freaza; Sampaio, Camila Alves] Hosp Geral Roberto Santos, Salvador, BA, Brazil.
   [Principe de Oliveira, Adriano Hasler; Magalhaes, Samuel de Araujo] Hosp Santa Luzia, Fundacao Colombo Spinola, Salvador, BA, Brazil.
   [Bandeira, Antonio Carlos] Fac Tecnol & Ciencias, Dept Infect Dis, Sch Med, Salvador, BA, Brazil.
   [Sardi, Silvia Ines; Soares, Gubio Campos] Univ Fed Bahia, Virol Lab, Salvador, BA, Brazil.
RP Rocha, VFD (corresponding author), Hosp Geral Roberto Santos, Salvador, BA, Brazil.
EM veronica.diniz.rocha@gmail.com
RI ; sardi, silvia ines/P-9349-2016
OI Rocha, Vanderson/0000-0003-0094-619X; sardi, silvia
   ines/0000-0002-2002-8436
FU Ministry of Education - Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior (CAPES) [88887-116628/2016]
FX This work was supported by the Ministry of Education - Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES)
   [88887-116628/2016].
CR Mahendradas P, 2010, INDIAN J OPHTHALMOL, V58, P545, DOI 10.4103/0301-4738.71707
   Martinez-Pulgarin DF, 2016, TRAVEL MED INFECT DI, V14, P451, DOI 10.1016/j.tmaid.2016.05.008
   Ministerio da Saude (BR), 2014, PREP RESP INTR VIR C
   Mittal A, 2007, OPHTHALMOLOGY, V114, P1798, DOI 10.1016/j.ophtha.2007.03.045
   Scripsema Nicole K, 2015, Retin Cases Brief Rep, V9, P352, DOI 10.1097/ICB.0000000000000232
NR 5
TC 4
Z9 4
U1 0
U2 1
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0927-3948
EI 1744-5078
J9 OCUL IMMUNOL INFLAMM
JI Ocul. Immunol. Inflamm.
PY 2018
VL 26
IS 5
BP 677
EP 679
DI 10.1080/09273948.2017.1358378
PG 3
WC Ophthalmology
SC Ophthalmology
GA GL7DG
UT WOS:000437355500006
PM 29020499
DA 2020-12-01
ER

PT J
AU Campos, GS
   Bandeira, ACA
   Rocha, VFD
   Dias, JP
   Carvalho, RH
   Sardi, SI
AF Campos, Gubio Soares
   Albuquerque Bandeira, Antonio Carlos
   Diniz Rocha, Veronica Franca
   Dias, Juarez Pereira
   Carvalho, Rejane Hughes
   Sardi, Silvia Ines
TI FIRST DETECTION OF CHIKUNGUNYA VIRUS IN BREAST MILK
SO PEDIATRIC INFECTIOUS DISEASE JOURNAL
LA English
DT Article
DE chikungunya; breast milk; chikungunya infection
ID DIAGNOSIS; TRANSMISSION
AB Chikungunya virus (CHIKV) has never been detected in human breast milk. This is a brief report of CHIKV infection in a breastfeeding woman of a 3-month-old baby. The mother's CHIKV-RT PCR was positive in serum, urine and milk. The baby's CHIKV serology and reverse transcription polimerase chain reaction (RT-PCR) were negative. The detection of CHIKV in milk raises clinical and epidemiologic questions.
C1 [Campos, Gubio Soares; Carvalho, Rejane Hughes; Sardi, Silvia Ines] Univ Fed Bahia, Virol Lab, Salvador, BA, Brazil.
   [Albuquerque Bandeira, Antonio Carlos] Fac Tecnol & Ciencias, Med Sch, Salvador, BA, Brazil.
   [Diniz Rocha, Veronica Franca] Univ Fed Bahia, Microbiol, Salvador, BA, Brazil.
   [Dias, Juarez Pereira] Univ Fed Bahia, Inst Saude Colet, Salvador, BA, Brazil.
RP Rocha, VFD (corresponding author), Univ Fed Bahia, Salvador, BA, Brazil.
EM veronica.diniz.rocha@gmail.com
FU Ministry of Education-Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior (CAPES) [88887-116628/2016]
FX Supported by the Ministry of Education-Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior (CAPES)-ZIKA FASTRACK NUMBER
   88887-116628/2016.
CR Bandeira AC, 2016, IDCases, V6, P100, DOI 10.1016/j.idcr.2016.10.007
   Bandeira AC, 2016, IDCases, V5, P57, DOI 10.1016/j.idcr.2016.07.008
   Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P877
   Couto A. Mallmann, 2010, Morbidity and Mortality Weekly Report, V59, P130
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Edwards CJ, 2007, J CLIN VIROL, V39, P271, DOI 10.1016/j.jcv.2007.05.008
   Grivard P, 2007, PATHOL BIOL, V55, P490, DOI 10.1016/j.patbio.2007.07.002
   Rodriguez-Morales Alfonso J, 2016, F1000Res, V5, P360, DOI 10.12688/f1000research.8235.1
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   WHO guidelines approved by the Guidelines Review Committee, 2016, GUID INF GUID INF FE
NR 10
TC 3
Z9 5
U1 1
U2 3
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0891-3668
EI 1532-0987
J9 PEDIATR INFECT DIS J
JI Pediatr. Infect. Dis. J.
PD OCT
PY 2017
VL 36
IS 10
BP 1015
EP 1017
DI 10.1097/INF.0000000000001658
PG 4
WC Immunology; Infectious Diseases; Pediatrics
SC Immunology; Infectious Diseases; Pediatrics
GA FM6QO
UT WOS:000415181000026
PM 28650420
DA 2020-12-01
ER

PT J
AU Bandeira, ACPCS
   Elias, DBD
   Cavalcante, MG
   Lima, DGL
   Tavora, LGF
AF Carmo Sa Bandeira, Antonio Carlos Policarpo
   Dias Elias, Darcielle Bruna
   Gadelha Cavalcante, Malena
   Limaverde Lima, Denise Girao
   Fernandes Tavora, Lara Gurgel
TI Antiretroviral changes during the first year of therapy
SO REVISTA DA ASSOCIACAO MEDICA BRASILEIRA
LA English
DT Article
DE acquired immunodeficiency syndrome; highly active antiretroviral
   therapy; human immunodeficiency virus
ID HIV-INFECTED PATIENTS; VIROLOGICAL FAILURE; PREDICTORS; RESISTANCE;
   REGIMENS; AFRICA; COHORT
AB Introduction: The Brazilian HIV/AIDS management and treatment guideline (PCDT), published in 2013, recommends and standardizes the use of highly active antiretroviral therapy (HAART) in all adult patients, in spite of LTCD4 count. This study aimed to analyze the first year of HAART use in patients from a reference center on HIV/AIDS management in Fortaleza, Ceara.
   Method: This descriptive study reviewed all prescription forms of antiretroviral regimens initiation and changes from January to July 2014. All antiretroviral regimen changes that occurred during the first year of therapy were evaluated. Data were analyzed with SPSS version 20. Mean, standard deviation and frequency, Student's t and Mann-Whitney tests calculations were used, with significance at p<0.05.
   Results: From 527 patients initiating HAART, 16.5% (n=87) had a regimen change in the first year. These patients were mostly male (59.8%; n=52), aged 20 to 39 years, with only one HAART change (72.4%; n=63). Efavirenz was the most often changed drug, followed by tenofovir, zidovudine and lopinavir/ritonavir. Mean time of HAART changes was 120 days, with adverse reactions as the most prevalent cause. HAART was effective in decreasing viral load since second month of treatment (p=0.003) and increasing LTCD4 lymphocytes since fifth month (p<0.001).
   Conclusion: The main cause of initial HAART changes was adverse reaction and most patients had only one change in the HAART regimen. HAART prescription was in accordance to the PCDT from 2013.
C1 [Carmo Sa Bandeira, Antonio Carlos Policarpo] Hosp Sao Jose de Doencas Infecciosas HSJ, Infectol, Escola Saude Publ Ceara ESP CE, Fortaleza, Ceara, Brazil.
   [Dias Elias, Darcielle Bruna] HSJ Lab, Fortaleza, Ceara, Brazil.
   [Gadelha Cavalcante, Malena] Ctr Farm CENFAR, HSJ, Fortaleza, Ceara, Brazil.
   [Limaverde Lima, Denise Girao] ESP CE, Hosp Pharm, Fortaleza, Ceara, Brazil.
   [Limaverde Lima, Denise Girao] CENFAR, HSJ, Fortaleza, Ceara, Brazil.
   [Fernandes Tavora, Lara Gurgel] Univ Sao Paulo, Infect & Parasit Dis, Fortaleza, Ceara, Brazil.
   [Fernandes Tavora, Lara Gurgel] HSJ, Fortaleza, Ceara, Brazil.
RP Bandeira, ACPCS (corresponding author), Rua Doutor Atualpa 1-034, BR-60321070 Fortaleza, Ceara, Brazil.
EM carlopolicarpo@gmail.com
CR Amoroso A, 2012, JAIDS-J ACQ IMM DEF, V60, P314, DOI 10.1097/QAI.0b013e31824e5256
   Asfaw A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122583
   Asmelash A, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-331
   Brasil. Ministerio da Saude, 2013, PROT CLIN DIR TER MA
   Carcelero E, 2011, HIV MED, V12, P494, DOI 10.1111/j.1468-1293.2011.00915.x
   Cicconi P, 2010, HIV MED, V11, P104, DOI 10.1111/j.1468-1293.2009.00750.x
   Eluwa George I, 2012, BMC Clin Pharmacol, V12, P7, DOI 10.1186/1472-6904-12-7
   Ferreira A. W., 2013, DIAGNOSTICO LAB PRIN
   Fox MP, 2012, JAIDS-J ACQ IMM DEF, V60, P428, DOI 10.1097/QAI.0b013e3182557785
   de Rossi SMG, 2012, REV PANAM SALUD PUBL, V32, P117, DOI 10.1590/S1020-49892012000800005
   Gunthard HF, 2014, JAMA-J AM MED ASSOC, V312, P410, DOI 10.1001/jama.2014.8722
   Jarrin I, 2013, ANTIVIR THER, V18, P161, DOI 10.3851/IMP2287
   Kalyesubula R, 2011, AFR HEALTH SCI, V11, P16
   Lima DGL, 2012, REV ASSOC MED BRAS, V58, P222, DOI 10.1590/S0104-42302012000200019
   Luebbert J, 2012, CLIN INFECT DIS, V55, P441, DOI 10.1093/cid/cis438
   Marconi VC, 2010, AIDS RES THER, V7, DOI 10.1186/1742-6405-7-14
   PEREIRA M. G, 2014, ARTIGOS CIENTIFICOS
   Prosperi MCF, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-296
   Rodrigues AL, 2010, REV SOC BRAS MED TRO, V43, P542, DOI 10.1590/S0037-86822010000500014
   Rokx C, 2015, CLIN INFECT DIS, V60, P143, DOI 10.1093/cid/ciu763
   Ryom L, 2016, HIV MED, V17, P83, DOI 10.1111/hiv.12322
   Saberi P, 2012, PATIENT PREFER ADHER, V6, P297, DOI 10.2147/PPA.S30244
   Sivadasan Ajith, 2009, J Assoc Physicians India, V57, P384
   Tang MW, 2012, DRUGS, V72, pE1, DOI 10.2165/11633630-000000000-00000
   Woldemedhin B, 2012, N AM J MED SCI, V4, P19, DOI 10.4103/1947-2714.92898
   Zheng Y, 2014, CLIN INFECT DIS, V59, P888, DOI 10.1093/cid/ciu367
NR 26
TC 2
Z9 4
U1 0
U2 3
PU ASSOC MEDICA BRASILEIRA
PI SAO PAULO
PA RUA SAO CARLOS DO PINHAL 324, CAIXA POSTAL 8904, SAO PAULO, SP, BRAZIL
SN 0104-4230
J9 REV ASSOC MED BRAS
JI Rev. Assoc. Med. Bras.
PD JUL
PY 2017
VL 63
IS 7
BP 606
EP 612
DI 10.1590/1806-9282.63.07.606
PG 7
WC Medicine, General & Internal
SC General & Internal Medicine
GA FI8VA
UT WOS:000412279000009
PM 28977086
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Bandeira, AC
   Campos, GS
   Ribeiro, GS
   Cardoso, CW
   Bastos, CJ
   Pessoa, TL
   Araujo, KA
   Grassi, MFR
   Castro, AP
   Carvalho, RH
   Prates, APPB
   Gois, LL
   Rocha, VF
   Sardi, SI
AF Bandeira, A. C.
   Campos, G. S.
   Ribeiro, G. S.
   Cardoso, C. W.
   Bastos, C. J.
   Pessoa, T. L.
   Araujo, K. A.
   Grassi, M. F. R.
   Castro, A. P.
   Carvalho, R. H.
   Prates, A. P. P. B.
   Gois, L. L.
   Rocha, V. F.
   Sardi, S. I.
TI Clinical and laboratory evidence of Haff disease - case series from an
   outbreak in Salvador, Brazil, December 2016 to April 2017
SO EUROSURVEILLANCE
LA English
DT Article
ID RHABDOMYOLYSIS; CHIKUNGUNYA; ZIKA
AB We describe a series of 15 Haff disease cases from an outbreak in Salvador, Brazil, starting early December 2016. Eleven cases were grouped in four family clusters of two to four individuals, four were isolated cases. All but one patient consumed cooked fish; 11 within 24h before symptoms onset. Cases consumed Olho de Boi' (Seriola spp.) and 'Badejo' (Mycteroperca spp.). A total of 67 cases were detected, the last case was reported on 5 April 2017.
C1 [Bandeira, A. C.; Bastos, C. J.; Pessoa, T. L.] Fac Tecnol & Ciencias, Med Sch, Salvador, BA, Brazil.
   [Bandeira, A. C.; Araujo, K. A.] Hosp Alianca, Salvador, BA, Brazil.
   [Bandeira, A. C.; Ribeiro, G. S.; Grassi, M. F. R.] Fiocruz MS, Inst Goncalo Moniz, Salvador, BA, Brazil.
   [Campos, G. S.; Carvalho, R. H.; Sardi, S. I.] Univ Fed Bahia, Virol Lab, Salvador, BA, Brazil.
   [Ribeiro, G. S.] Univ Fed Bahia, Inst Saude Colet, Salvador, BA, Brazil.
   [Cardoso, C. W.; Prates, A. P. P. B.] Secretaria Municipal Saude, Salvador, BA, Brazil.
   [Castro, A. P.] Hosp Aeroporto, Salvador, BA, Brazil.
   [Gois, L. L.] Univ Catolica Salvador, Salvador, BA, Brazil.
   [Rocha, V. F.] Hosp Geral Roberto Santos, Salvador, BA, Brazil.
RP Bandeira, AC (corresponding author), Fac Tecnol & Ciencias, Med Sch, Salvador, BA, Brazil.; Bandeira, AC (corresponding author), Hosp Alianca, Salvador, BA, Brazil.; Bandeira, AC (corresponding author), Fiocruz MS, Inst Goncalo Moniz, Salvador, BA, Brazil.
EM antoniobandeira@gmail.com
RI Cardoso, Cristiane W/U-3350-2019; Grassi, Fernanda/X-7360-2019; Ribeiro,
   Guilherme/B-6624-2008
OI Grassi, Fernanda/0000-0002-7356-5569; Ribeiro,
   Guilherme/0000-0002-6798-2059; Cardoso, Cristiane/0000-0001-5432-1174
CR Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Boletim Epidemiologico, 2017, SECR MUN SAUD SAL MI
   Botana Luis M., 2008, P149
   Cardoso CW, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005334
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Centers for Disease Control and Prevention (CDC), 1998, MMWR Morb Mortal Wkly Rep, V47, P1091
   Diaz JH, 2015, CLIN TOXICOL, V53, P421, DOI 10.3109/15563650.2015.1016165
   dos Santos MC, 2009, REV PANAM SALUD PUBL, V26, P469, DOI 10.1590/S1020-49892009001100012
   Edwards CJ, 2007, J CLIN VIROL, V39, P271, DOI 10.1016/j.jcv.2007.05.008
   Herman LL, 2014, WEST J EMERG MED, V15, P664, DOI 10.5811/westjem.2014.6.10.21794
   Kim SY, 2012, BIOMOL THER, V20, P268, DOI 10.4062/biomolther.2012.20.3.268
   Langley RL, 2007, SOUTH MED J, V100, P1147, DOI 10.1097/SMJ.0b013e3181583673
   Mizuta K, 2012, EMERG INFECT DIS, V18, P1787, DOI 10.3201/eid1811.111570
   Nix WA, 2006, J CLIN MICROBIOL, V44, P2698, DOI 10.1128/JCM.00542-06
   Oberste MS, 1999, J MED VIROL, V58, P178, DOI 10.1002/(SICI)1096-9071(199906)58:2&lt;178::AID-JMV13&gt;3.0.CO;2-Q
   Paul V, 2014, QJM-INT J MED, V107, P67, DOI 10.1093/qjmed/hct172
   Thoelen I, 2003, J MED VIROL, V70, P420, DOI 10.1002/jmv.10412
   Tolesani Junior Oswaldo, 2013, Rev. bras. ter. intensiva, V25, P348, DOI 10.5935/0103-507X.20130058
   Zhang B, 2012, INTERNAL MED, V51, P487, DOI 10.2169/internalmedicine.51.6786
   Zu J. B., 1939, ERGEBNISSE INNEREN M, V57, P138
NR 20
TC 2
Z9 2
U1 0
U2 12
PU EUR CENTRE DIS PREVENTION & CONTROL
PI STOCKHOLM
PA TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN
SN 1560-7917
J9 EUROSURVEILLANCE
JI Eurosurveillance
PD JUN 15
PY 2017
VL 22
IS 24
BP 2
EP 6
DI 10.2807/1560-7917.ES.2017.22.24.30552
PG 5
WC Infectious Diseases
SC Infectious Diseases
GA EX9RR
UT WOS:000403596000001
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Tauro, LB
   Bandeira, AC
   Ribeiro, GS
   Reis, MG
   Pizarro, CPRM
   Araujo, KA
   Castro, AP
   Queiroz, JM
   Simon, SS
   Menezes, G
   Campos, GS
   Sardi, S
AF Tauro, L. B.
   Bandeira, A. C.
   Ribeiro, G. S.
   Reis, M. G.
   Pizarro, C. P. R. M.
   Araujo, K. A.
   Castro, A. P.
   Queiroz, J. M.
   Simon, S. S.
   Menezes, G.
   Campos, G. S.
   Sardi, S.
TI Potential use of saliva samples to diagnose Zika virus infection
SO JOURNAL OF MEDICAL VIROLOGY
LA English
DT Letter
C1 [Tauro, L. B.; Ribeiro, G. S.; Reis, M. G.] Oswaldo Cruz Fdn FIOCRUZ, Goncalo Moniz Res Ctr, Waldemar Falcao 121, BR-40296710 Salvador, BA, Brazil.
   [Bandeira, A. C.; Pizarro, C. P. R. M.; Araujo, K. A.; Castro, A. P.; Queiroz, J. M.; Simon, S. S.] Hosp Alianca, Salvador, BA, Brazil.
   [Bandeira, A. C.] Bahiana Sch Med, Salvador, BA, Brazil.
   [Bandeira, A. C.] Fac Sci & Technol, Salvador, BA, Brazil.
   [Ribeiro, G. S.] Univ Fed Bahia, Inst Collect Hlth, Salvador, BA, Brazil.
   [Reis, M. G.] Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.
   [Reis, M. G.] Univ Fed Bahia, Sch Med, Salvador, BA, Brazil.
   [Menezes, G.; Campos, G. S.; Sardi, S.] Univ Fed Bahia, Inst Hlth Sci, Virol Lab, Salvador, BA, Brazil.
RP Tauro, LB (corresponding author), Oswaldo Cruz Fdn FIOCRUZ, Goncalo Moniz Res Ctr, Waldemar Falcao 121, BR-40296710 Salvador, BA, Brazil.
EM lauratauro@gmail.com
RI Ribeiro, Guilherme/B-6624-2008; Reis, Mitermayer/AAO-9742-2020; sardi,
   silvia ines/P-9349-2016
OI Ribeiro, Guilherme/0000-0002-6798-2059; Reis,
   Mitermayer/0000-0002-3051-9060; sardi, silvia ines/0000-0002-2002-8436
CR Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.10.30159
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Corstjens PLAM, 2016, PERIODONTOL 2000, V70, P93, DOI 10.1111/prd.12112
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Hamel R, 2016, MICROBES INFECT, V18, DOI 10.1016/j.micinf.2016.03.009
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Poloni TR, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-22
NR 10
TC 13
Z9 13
U1 0
U2 36
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0146-6615
EI 1096-9071
J9 J MED VIROL
JI J. Med. Virol.
PD JAN
PY 2017
VL 89
IS 1
BP 1
EP 2
DI 10.1002/jmv.24696
PG 2
WC Virology
SC Virology
GA EB2CR
UT WOS:000387165200001
PM 27671098
DA 2020-12-01
ER

PT J
AU Souza, BSF
   Sampaio, GLA
   Pereira, CS
   Campos, GS
   Sardi, SI
   Freitas, LAR
   Figueira, CP
   Paredes, BD
   Nonaka, CKV
   Azevedo, CM
   Rocha, VPC
   Bandeira, AC
   Mendez-Otero, R
   dos Santos, RR
   Soares, MBP
AF Souza, Bruno S. F.
   Sampaio, Gabriela L. A.
   Pereira, Ciro S.
   Campos, Gubio S.
   Sardi, Silvia I.
   Freitas, Luiz A. R.
   Figueira, Claudio P.
   Paredes, Bruno D.
   Nonaka, Carolina K. V.
   Azevedo, Carine M.
   Rocha, Vinicius P. C.
   Bandeira, Antonio C.
   Mendez-Otero, Rosalia
   dos Santos, Ricardo Ribeiro
   Soares, Milena B. P.
TI Zika virus infection induces mitosis abnormalities and apoptotic cell
   death of human neural progenitor cells
SO SCIENTIFIC REPORTS
LA English
DT Article
ID STEM-CELLS; BRAIN; MICRONESIA; ORGANOIDS; AUTOPHAGY; OUTBREAK; BRAZIL;
   MODEL
AB Zika virus (ZIKV) infection has been associated with severe complications both in the developing and adult nervous system. To investigate the deleterious effects of ZIKV infection, we used human neural progenitor cells (NPC), derived from induced pluripotent stem cells (iPSC). We found that NPC are highly susceptible to ZIKV and the infection results in cell death. ZIKV infection led to a marked reduction in cell proliferation, ultrastructural alterations and induction of autophagy. Induction of apoptosis of Sox2(+) cells was demonstrated by activation of caspases 3/7, 8 and 9, and by ultrastructural and flow cytometry analyses. ZIKV-induced death of Sox2+ cells was prevented by incubation with the pan-caspase inhibitor, Z-VAD-FMK. By confocal microscopy analysis we found an increased number of cells with supernumerary centrosomes. Live imaging showed a significant increase in mitosis abnormalities, including multipolar spindle, chromosome laggards, micronuclei and death of progeny after cell division. FISH analysis for chromosomes 12 and 17 showed increased frequency of aneuploidy, such as monosomy, trisomy and polyploidy. Our study reinforces the link between ZIKV and abnormalities in the developing human brain, including microcephaly.
C1 [Souza, Bruno S. F.; Pereira, Ciro S.; Freitas, Luiz A. R.; Figueira, Claudio P.; Nonaka, Carolina K. V.; Azevedo, Carine M.; Rocha, Vinicius P. C.; Soares, Milena B. P.] Fiocruz MS, Goncalo Moniz Inst, BR-40296710 Salvador, BA, Brazil.
   [Souza, Bruno S. F.; Sampaio, Gabriela L. A.; Paredes, Bruno D.; Nonaka, Carolina K. V.; Azevedo, Carine M.; Rocha, Vinicius P. C.; dos Santos, Ricardo Ribeiro; Soares, Milena B. P.] Sao Rafael Hosp, Ctr Biotechnol & Cell Therapy, BR-41253190 Salvador, BA, Brazil.
   [Campos, Gubio S.; Sardi, Silvia I.] Univ Fed Bahia, Virol Lab, BR-40110100 Salvador, BA, Brazil.
   [Freitas, Luiz A. R.] Fed Univ Bahia Salvador, Dept Pathol, BR-40110100 Salvador, BA, Brazil.
   [Bandeira, Antonio C.] Hosp Couto Maia, BR-40425060 Salvador, BA, Brazil.
   [Mendez-Otero, Rosalia] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, BR-21941902 Rio De Janeiro, RJ, Brazil.
RP Souza, BSF; Soares, MBP (corresponding author), Fiocruz MS, Goncalo Moniz Inst, BR-40296710 Salvador, BA, Brazil.; Souza, BSF; Soares, MBP (corresponding author), Sao Rafael Hosp, Ctr Biotechnol & Cell Therapy, BR-41253190 Salvador, BA, Brazil.
EM bruno.souza@bahia.fiocruz.br; milena@bahia.fiocruz.br
RI Mendez-Otero, Rosalia/AAL-7551-2020; Freitas, Luis/AAA-1784-2019; sardi,
   silvia ines/P-9349-2016
OI Mendez-Otero, Rosalia/0000-0002-1798-9930; sardi, silvia
   ines/0000-0002-2002-8436; Sampaio, Gabriela/0000-0002-9955-258X
FU Brazilian government through CAPES (Zika FastTrack); FINEPCiencia
   Tecnologia e Inovacao (FINEP); FAPERJCarlos Chagas Filho Foundation for
   Research Support of the State of Rio de Janeiro (FAPERJ); FAPESB;
   CNPqNational Council for Scientific and Technological Development (CNPq)
FX The authors wish to thank Dr. Cecilia Laterza for helpful comments on
   the manuscript. This study was supported by funds from the Brazilian
   government, through CAPES (Zika FastTrack), FINEP, FAPERJ and FAPESB.
   Milena B. P. Soares, Rosalia Mendez-Otero and Ricardo Ribeiro dos Santos
   are recipients of CNPq fellowships.
CR Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Camp JG, 2015, P NATL ACAD SCI USA, V112, P15672, DOI 10.1073/pnas.1520760112
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Carneiro LAM, 2016, MICROBES INFECT, V18, P169, DOI 10.1016/j.micinf.2015.12.006
   Chung KM, 2013, BMB REP, V46, P383, DOI 10.5483/BMBRep.2013.46.8.164
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   de Oliveira WK, 2016, MMWR-MORBID MORTAL W, V65
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Hennessey M., 2015, CTR DIS CONTROL PREV, V65, P55, DOI DOI 10.15585/MMWR.MM6503E1
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Jouannic JM, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00625-5
   Kita-Matsuo H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005046
   Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600
   Kudchodkar SB, 2009, REV MED VIROL, V19, P359, DOI 10.1002/rmv.630
   Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Marthiens V, 2013, NAT CELL BIOL, V15, P731, DOI 10.1038/ncb2746
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/nmeth.1591, 10.1038/NMETH.1591]
   Pan American Health Organization/ World Health Organization, 2016, ZIK EP UPD 17 MARCH
   Salonen A, 2005, CURR TOP MICROBIOL, V285, P139
   Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Thornton GK, 2009, TRENDS GENET, V25, P501, DOI 10.1016/j.tig.2009.09.011
   Triunfol M, 2016, LANCET INFECT DIS, V16, P156, DOI 10.1016/S1473-3099(15)00548-4
   Walker TL, 2007, J NEUROSCI, V27, P3734, DOI 10.1523/JNEUROSCI.5060-06.2007
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
NR 37
TC 77
Z9 77
U1 0
U2 32
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD DEC 23
PY 2016
VL 6
AR 39775
DI 10.1038/srep39775
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EG0XV
UT WOS:000390756600004
PM 28008958
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Naccache, SN
   Theze, J
   Sardi, SI
   Somasekar, S
   Greninger, AL
   Bandeira, AC
   Campos, GS
   Tauro, LB
   Faria, NR
   Pybus, OG
   Chiu, CY
AF Naccache, Samia N.
   Theze, Julien
   Sardi, Silvia I.
   Somasekar, Sneha
   Greninger, Alexander L.
   Bandeira, Antonio C.
   Campos, Gubio S.
   Tauro, Laura B.
   Faria, Nuno R.
   Pybus, Oliver G.
   Chiu, Charles Y.
TI Distinct Zika Virus Lineage in Salvador, Bahia, Brazil
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID OUTBREAK
AB Sequencing of isolates from patients in Bahia, Brazil, where most Zika virus cases in Brazil have been reported, resulted in 11 whole and partial Zika virus genomes. Phylogenetic analyses revealed a well-supported Bahia-specific Zika virus lineage, which indicates sustained Zika virus circulation in Salvador, Bahia's capital city, since mid-2014.
C1 [Naccache, Samia N.; Somasekar, Sneha; Chiu, Charles Y.] Univ Calif San Francisco, San Francisco, CA 94143 USA.
   [Naccache, Samia N.; Somasekar, Sneha; Chiu, Charles Y.] Univ Calif San Francisco, Abbott Viral Diagnost & Discovery Ctr, San Francisco, CA 94143 USA.
   [Theze, Julien; Faria, Nuno R.; Pybus, Oliver G.] Univ Oxford, Oxford, England.
   [Sardi, Silvia I.; Campos, Gubio S.] Univ Fed Bahia, Salvador, BA, Brazil.
   [Greninger, Alexander L.] Univ Washington, Seattle, WA 98195 USA.
   [Bandeira, Antonio C.] Hosp Alianca, Salvador, BA, Brazil.
   [Tauro, Laura B.] Fundacao Oswaldo Cruz, Goncalo Moniz Res Ctr, Salvador, BA, Brazil.
   [Faria, Nuno R.] Evandro Chagas Inst, Ananindeua, Brazil.
RP Chiu, CY (corresponding author), Univ Calif San Francisco, UCSF China Basin, 185 Berry St,Box 0134, San Francisco, CA 94107 USA.
EM charles.chiu@ucsf.edu
RI Pybus, Oliver G/B-2640-2012; Faria, Nuno R/I-2975-2012; sardi, silvia
   ines/P-9349-2016
OI Pybus, Oliver G/0000-0002-8797-2667; Faria, Nuno R/0000-0001-8839-2798;
   sardi, silvia ines/0000-0002-2002-8436; Greninger,
   Alexander/0000-0002-7443-0527; Theze, Julien/0000-0001-8188-9494
FU Fundacao de Amparo a Pesquisa do Estado da Bahia; European Research
   Council under the European Union's Seventh Framework Program (FP7)/ERC
   [614725-PATHPHYLODYN]; National Institutes of HealthUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [R01-HL105704, R21-AI120977]; Abbott Laboratories, Inc.Abbott
   Laboratories; American people through the United States Agency for
   International Development Emerging Pandemic Threats Program-2
   PREDICT-2United States Agency for International Development (USAID)
   [AID-OAA-A-14-00102]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)
   [R01HL105704, R01HL105704, R01HL105704, R01HL105704, R01HL105704,
   R01HL105704, R01HL105704, R01HL105704, R01HL105704] Funding Source: NIH
   RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [R21AI120977, R21AI120977] Funding Source: NIH RePORTER
FX This study was supported in part by Fundacao de Amparo a Pesquisa do
   Estado da Bahia, the European Research Council under the European
   Union's Seventh Framework Program (FP7/2007-2013)/ERC grant agreement
   no. 614725-PATHPHYLODYN, National Institutes of Health grants
   R01-HL105704 and R21-AI120977 (C.Y.C.), and a viral discovery award from
   Abbott Laboratories, Inc. (C.Y.C.). This study was made possible by the
   generous support of the American people through the United States Agency
   for International Development Emerging Pandemic Threats Program-2
   PREDICT-2 (Cooperative Agreement No. AID-OAA-A-14-00102).
CR Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Chiu CY, 2015, EMERG INFECT DIS, V21, P1409, DOI 10.3201/eid2108.150458
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Giovanetti M, 2016, INFECT GENET EVOL, V41, P142, DOI 10.1016/j.meegid.2016.03.030
   Greninger AL, 2015, LANCET INFECT DIS, V15, P671, DOI 10.1016/S1473-3099(15)70093-9
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Naccache SN, 2014, GENOME RES, V24, P1180, DOI 10.1101/gr.171934.113
   Rubin EJ, 2016, NEW ENGL J MED, V374, P984, DOI 10.1056/NEJMe1601862
   Sardi SI, 2016, J CLIN MICROBIOL IN
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 15
TC 26
Z9 27
U1 1
U2 24
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD OCT
PY 2016
VL 22
IS 10
BP 1788
EP 1792
DI 10.3201/eid2210.160663
PG 5
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA DX4YQ
UT WOS:000384387400013
PM 27448188
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Falcao, MB
   Cimerman, S
   Luz, KG
   Chebabo, A
   Brigido, HA
   Lobo, IM
   Timerman, A
   Angerami, RN
   da Cunha, CA
   Bacha, HA
   Alves, JR
   Barbosa, AN
   Teixeira, RF
   Weissmann, L
   Oliveira, PR
   Cyrillo, MA
   Bandeira, AC
AF Falcao, Melissa Barreto
   Cimerman, Sergio
   Luz, Kleber Giovanni
   Chebabo, Alberto
   Brigido, Helena Andrade
   Lobo, Iza Maria
   Timerman, Artur
   Angerami, Rodrigo Nogueira
   da Cunha, Clovis Arns
   Bacha, Helio Arthur
   Alves, Jesse Reis
   Barbosa, Alexandre Naime
   Teixeira, Ralcyon Francis
   Weissmann, Leonardo
   Oliveira, Priscila Rosalba
   Cyrillo, Marco Antonio
   Bandeira, Antonio Carlos
TI Management of infection by the Zika virus
SO ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS
LA English
DT Review
DE Zika virus infection; Guideline; Diagnosis; Therapeutics
ID FRENCH-POLYNESIA; OUTBREAK; TRANSMISSION; EPIDEMIOLOGY; STATES; BRAZIL
AB A panel of national experts was convened by the Brazilian Infectious Diseases Society in order to organize the national recommendations for the management of zika virus infection. The focus of this document is the diagnosis, both clinical and laboratorial, and appropriate treatment of the diverse manifestations of this infection, ranging from acute mild disease to Guillain-Barre syndrome and also microcephaly and congenital malformations.
C1 [Falcao, Melissa Barreto] Univ Estadual Feira de Santana, Ave Transnordestina S-N, BR-44036900 Feira De Santana, BA, Brazil.
   [Cimerman, Sergio; Alves, Jesse Reis; Teixeira, Ralcyon Francis; Weissmann, Leonardo] Inst Infectol Emilio Ribas, Ave Doutor Arnaldo 165, BR-01246000 Sao Paulo, SP, Brazil.
   [Luz, Kleber Giovanni] Univ Fed Rio Grande do Norte, Rua Conego Monte S-N, BR-59037170 Natal, RN, Brazil.
   [Chebabo, Alberto] Univ Fed Rio de Janeiro, Ave Prof Rodolpho Paulo Rocco 255,50 Andar, BR-21941913 Rio De Janeiro, RJ, Brazil.
   [Brigido, Helena Andrade] Fed Univ Para, Rua Mundurucus S-N, BR-66060060 Belem, Para, Brazil.
   [Lobo, Iza Maria] Univ Fed Sergipe, Ave Claudio Batista S-N,30 Andar, BR-49060100 Aracaju, SE, Brazil.
   [Timerman, Artur] Hosp Prof Edmundo Vasconcelos, Rua Borges Lagoa 1450, BR-04038905 Sao Paulo, SP, Brazil.
   [Angerami, Rodrigo Nogueira] Univ Estadual Campinas, Rua Alexander Fleming 181, BR-13083970 Campinas, SP, Brazil.
   [da Cunha, Clovis Arns] Univ Fed Parana, Rua Gen Carneiro 181, BR-80060900 Curitiba, Parana, Brazil.
   [Bacha, Helio Arthur] Hosp Israelita Albert Einstein, Ave Albert Einstein 627,Bloco A1,Sala 220, BR-05651901 Sao Paulo, SP, Brazil.
   [Oliveira, Priscila Rosalba] Univ Sao Paulo, Rua Doutor Ovidio Pires Campos 333, BR-05403010 Sao Paulo, SP, Brazil.
   [Cyrillo, Marco Antonio] Hosp Servidor Publ Municipal, Rua Castro Alves 60, BR-01532000 Sao Paulo, SP, Brazil.
   [Bandeira, Antonio Carlos] Hosp Alianca, R Juracy Magalhaes Jr 2096, BR-41920000 Salvador, BA, Brazil.
RP Oliveira, PR (corresponding author), Univ Sao Paulo, Rua Doutor Ovidio Pires Campos 333, BR-05403010 Sao Paulo, SP, Brazil.
EM priscila.rosalba@hc.fm.usp.br
RI Weissmann, Leonardo/S-4605-2019; Oliveira, Priscila Rosalba/J-7531-2012;
   Barbosa, Alexandre Naime/F-5668-2012; Angerami, Rodrigo
   Nogueira/A-8926-2013; Bacha, Helio Arthur/AAU-8306-2020; CIMERMAN,
   SERGIO/I-4981-2014
OI Weissmann, Leonardo/0000-0002-4702-3221; Oliveira, Priscila
   Rosalba/0000-0003-1377-6556; Barbosa, Alexandre
   Naime/0000-0002-2187-4722; Angerami, Rodrigo
   Nogueira/0000-0002-4976-9238; Bacha, Helio Arthur/0000-0003-4269-0065;
   CIMERMAN, SERGIO/0000-0003-4040-220X
CR [Anonymous], 2015, RAP RISK ASS ZIK VIR
   [Anonymous], 2016, BRAZIL REPORTS ZIKA
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Brasil Ministerio da Saude, 2015, PROT VIG RESP OC MIC
   BRASIL. Ministerio da Saude, 2016, PROT VIG RESP OC MIC
   BRASIL. Ministerio da Saude, 2016, NOT INF
   Brasil P, 2016, NEW ENGL J MED, DOI [10.1056/nejmMoa1602412, DOI 10.1056/NEJMMOA1602412]
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Centers for Disease Control and Prevention, ZIK VIR SYMPT DIAGN
   Centers for Disease Control and Prevention, ZIK VIR TRANSM
   De Noronha L, 2015, MEM I O CRUZ RIO DE, V110, P569
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Federacao Brasileira das Associacoes de Ginecologia e Obstetricia, 2016, OR REC FEBRASGO INF
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   LaBeaud AD, 2016, ZIKA VIRUS INFECT OV
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Meaney-Delman D, 2016, OBSTET GYNECOL, V128, P724, DOI 10.1097/AOG.0000000000001625
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Pan American Health Organization, 2016, WHO ZIK SIT REP 21 J
   Pan American Health Organization, 2016, EP UPD NEUR SYNDR CO
   Paniz-Mondolfi AE, 2016, ANN CLIN MICROB ANTI, V15, DOI 10.1186/s12941-016-0157-x
   Parreira R, 2013, CHIKUNGUNIYA ZIKA VI, V54, P9
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Prisant N, 2016, LANCET INFECT DIS, V16, P1000, DOI 10.1016/S1473-3099(16)30193-1
   Rabe IB, 2016, MMWR MORB MORTAL REP, DOI 10.15585/mmwr.mm6521e1
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rodriguez-Morales AJ, 2015, ARCH MED, V11
   Rodriguez-Morales AJ, 2016, ANN CLIN MICROB ANTI, V15, DOI 10.1186/s12941-016-0128-2
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P5, DOI 10.1016/j.tmaid.2016.01.011
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Silvia Sardi, 2016, J CLIN MICROBIOL, DOI [10.1128/JCM.00877-16, DOI 10.1128/JCM.00877-16]
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Villamil-Gomez WE, 2016, J INFECT PUBLIC HEAL, V9, P684, DOI 10.1016/j.jiph.2015.12.002
   Villar J, 2016, LANCET, V387, P844, DOI 10.1016/S0140-6736(16)00384-6
   World Health Organization, ZIK VIR MICR GUILL B
   World Health Organization-, ID MAN GUILL BARR SY
   World Health Organization, GUILL BARR SYNDR BRA
   Yuki N, 2012, NEW ENGL J MED, V366, P2294, DOI 10.1056/NEJMra1114525
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 56
TC 13
Z9 13
U1 0
U2 67
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1476-0711
J9 ANN CLIN MICROB ANTI
JI Ann. Clin. Microbiol. Antimicrob.
PD SEP 29
PY 2016
VL 15
AR 57
DI 10.1186/s12941-016-0172-y
PG 15
WC Microbiology
SC Microbiology
GA DX4QR
UT WOS:000384366700001
PM 27686610
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Bandeira, AC
   Magalhaes, J
   Ramos, KD
AF Bandeira, Antonio Carlos
   Magalhaes Filho, Jose
   Ramos, Karine de Almeida
TI Reversible cardiomyopathy secondary to Amphotericin-B
SO MEDICAL MYCOLOGY CASE REPORTS
LA English
DT Article
DE AIDS; Cardiomyopathy; Amphotericin-B; Meningitis
ID DILATED CARDIOMYOPATHY; THERAPY
AB We describe a 32-yr old woman with AIDS and cryptococcal meningitis that developed cardiomyopathy after 17 days of treatment with Deoxycholate Amphotericin-B (D-Amb) with reversal of the symptoms and transthoracic echocardiogram (TTE) findings after the drug had been stopped and switched to Fluconazole
C1 [Bandeira, Antonio Carlos] Hosp Couto Maia, Sch Med, Fac Ciencias & Tecnol, Rua Sao Francisco S-N Monte Serrat, BR-40425060 Salvador, BA, Brazil.
   [Magalhaes Filho, Jose; Ramos, Karine de Almeida] Hosp Couto Maia, Rua Sao Francisco S-N Monte Serrat, BR-40425060 Salvador, BA, Brazil.
RP Bandeira, AC (corresponding author), Hosp Couto Maia, Sch Med, Fac Ciencias & Tecnol, Rua Sao Francisco S-N Monte Serrat, BR-40425060 Salvador, BA, Brazil.
CR ARSURA EL, 1994, AM J MED, V97, P560, DOI 10.1016/0002-9343(94)90353-0
   CHUNG DK, 1971, AM REV RESPIR DIS, V103, P831
   CRAVEN PC, 1985, ANTIMICROB AGENTS CH, V27, P868, DOI 10.1128/AAC.27.5.868
   Danaher PJ, 2004, J ANTIMICROB CHEMOTH, V53, P115, DOI 10.1093/jac/dkg472
   Groot OA, 2008, NETH J MED, V66, P433
   Moyssakis I, 2005, INT J ANTIMICROB AG, V25, P444, DOI 10.1016/j.ijantimicag.2005.02.015
   Soares JR, 2015, J CLIN PHARM THER, V40, P333, DOI 10.1111/jcpt.12237
NR 7
TC 2
Z9 2
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 2211-7539
J9 MED MYCOL CASE REP
JI Med. Mycol. Case Rep.
PD SEP
PY 2016
VL 13
BP 19
EP 21
DI 10.1016/j.mmcr.2016.10.001
PG 3
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA EM4FH
UT WOS:000395268400006
PM 27766195
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Sardi, SI
   Somasekar, S
   Naccache, SN
   Bandeira, AC
   Tauro, LB
   Campos, GS
   Chiu, CY
AF Sardi, Silvia I.
   Somasekar, Sneha
   Naccache, Samia N.
   Bandeira, Antonio C.
   Tauro, Laura B.
   Campos, Gubio S.
   Chiu, Charles Y.
TI Coinfections of Zika and Chikungunya Viruses in Bahia, Brazil,
   Identified by Metagenomic Next-Generation Sequencing
SO JOURNAL OF CLINICAL MICROBIOLOGY
LA English
DT Article
ID CLINICAL-SAMPLES; DENGUE VIRUSES; REAL-TIME; OUTBREAK; AMERICA; GENOME
AB Metagenomic next-generation sequencing (mNGS) of samples from 15 patients with documented Zika virus (ZIKV) infection in Bahia, Brazil, from April 2015 to January 2016 identified coinfections with chikungunya virus (CHIKV) in 2 of 15 ZIKV-positive cases by PCR (13.3%). While generally nonspecific, the clinical presentation corresponding to these two CHIKV/ZIKV coinfections reflected infection by the virus present at a higher titer. Aside from CHIKV and ZIKV, coinfections of other viral pathogens were not detected. The mNGS approach is promising for differential diagnosis of acute febrile illness and identification of coinfections, although targeted arbovirus screening may be sufficient in the current ZIKV outbreak setting.
C1 [Sardi, Silvia I.; Campos, Gubio S.] Univ Fed Bahia, Hlth Inst Sci, Virol Lab, Salvador, BA, Brazil.
   [Somasekar, Sneha; Naccache, Samia N.; Chiu, Charles Y.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA.
   [Somasekar, Sneha; Naccache, Samia N.; Chiu, Charles Y.] UCSF Abbott Viral Diagnost & Discovery Ctr, San Francisco, CA USA.
   [Bandeira, Antonio C.] Alianca Hosp, Salvador, BA, Brazil.
   [Tauro, Laura B.] Oswaldo Cruz Fdn FIOCRUZ, Goncalo Moniz Res Ctr, Salvador, BA, Brazil.
   [Chiu, Charles Y.] Univ Calif San Francisco, Dept Med, Div Infect Dis, San Francisco, CA USA.
RP Chiu, CY (corresponding author), Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA.; Chiu, CY (corresponding author), UCSF Abbott Viral Diagnost & Discovery Ctr, San Francisco, CA USA.; Chiu, CY (corresponding author), Univ Calif San Francisco, Dept Med, Div Infect Dis, San Francisco, CA USA.
EM charles.chiu@ucsf.edu
RI sardi, silvia ines/P-9349-2016
OI sardi, silvia ines/0000-0002-2002-8436
FU HHS \ National Institutes of Health (NIH)United States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USA
   [R01-HL105704, R21-AI120977]; Abbott LaboratoriesAbbott Laboratories;
   NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Heart Lung & Blood Institute (NHLBI) [R01HL105704, R01HL105704,
   R01HL105704, R01HL105704, R01HL105704, R01HL105704, R01HL105704,
   R01HL105704, R01HL105704] Funding Source: NIH RePORTER; NATIONAL
   INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)
   [R21AI120977, R21AI120977] Funding Source: NIH RePORTER
FX This work, including the efforts of Charles Y. Chiu, was funded by HHS
   vertical bar National Institutes of Health (NIH) (R01-HL105704 and
   R21-AI120977). This work, including the efforts of Charles Y. Chiu, was
   funded by Abbott Laboratories.
CR Baishya R, 2010, UROL ANNALS, V2, P110, DOI 10.4103/0974-7796.68859
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Centers for Disease Control and Prevention, 2016, REV DIAGN TEST ZIK C
   Cheval J, 2011, J CLIN MICROBIOL, V49, P3268, DOI 10.1128/JCM.00850-11
   Chiu CY, 2015, EMERG INFECT DIS, V21, P1409, DOI 10.3201/eid2108.150458
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Flygare S, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0969-1
   Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657
   Goldberg B, 2015, MBIO, V6, DOI 10.1128/mBio.01888-15
   Greninger AL, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0235-2
   Greninger AL, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0220-9
   Greninger AL, 2015, LANCET INFECT DIS, V15, P671, DOI 10.1016/S1473-3099(15)70093-9
   Carod-Artal FJ, 2013, LANCET NEUROL, V12, P906, DOI 10.1016/S1474-4422(13)70150-9
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Naccache SN, 2014, GENOME RES, V24, P1180, DOI 10.1101/gr.171934.113
   Naccache SN, 2016, EMERG INFECT DIS
   Pfeffer M, 2002, J VET MED B, V49, P49, DOI 10.1046/j.1439-0450.2002.00535.x
   Quick J, 2016, NATURE, V530, P228, DOI 10.1038/nature16996
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Villamil-Gomez WE, 2016, J INFECT PUBLIC HEAL, V9, P684, DOI 10.1016/j.jiph.2015.12.002
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
   Wood DE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r46
   Wylie TN, 2015, GENOME RES, V25, P1910, DOI 10.1101/gr.191049.115
NR 29
TC 61
Z9 61
U1 0
U2 9
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0095-1137
EI 1098-660X
J9 J CLIN MICROBIOL
JI J. Clin. Microbiol.
PD SEP
PY 2016
VL 54
IS 9
BP 2348
EP 2353
DI 10.1128/JCM.00877-16
PG 6
WC Microbiology
SC Microbiology
GA DX3CT
UT WOS:000384251300024
PM 27413190
OA Bronze, Green Published
DA 2020-12-01
ER

PT J
AU Rodriguez-Morales, AJ
   Bandeira, AC
   Franco-Paredes, C
AF Rodriguez-Morales, Alfonso J.
   Bandeira, Antonio Carlos
   Franco-Paredes, Carlos
TI The expanding spectrum of modes of transmission of Zika virus: a global
   concern
SO ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS
LA English
DT Editorial Material
ID INFECTION; AMERICA; THREAT
C1 [Rodriguez-Morales, Alfonso J.] Univ Tecnol Pereira, Fac Hlth Sci, Publ Hlth & Infect Res Grp, Pereira, Risaralda, Colombia.
   [Rodriguez-Morales, Alfonso J.] OLFIS, Bucaramanga, Santander, Colombia.
   [Bandeira, Antonio Carlos] Hosp Alianca, Salvador, BA, Brazil.
   [Bandeira, Antonio Carlos] Fac Ciencias & Tecnol, Sch Med, Salvador, BA, Brazil.
   [Franco-Paredes, Carlos] Phoebe Putney Mem Hosp, Albany, GA USA.
   [Franco-Paredes, Carlos] Hosp Infantil Mexico Dr Federico Gomez, Mexico City, DF, Mexico.
RP Rodriguez-Morales, AJ (corresponding author), Univ Tecnol Pereira, Fac Hlth Sci, Publ Hlth & Infect Res Grp, Pereira, Risaralda, Colombia.
EM ajrodriguezmmd@gmail.com
RI Franco-Paredes, Carlos/R-4226-2019; AJ, Rodriguez-Morales/R-9765-2016
OI AJ, Rodriguez-Morales/0000-0001-9773-2192
CR Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Campos RD, 2016, J CLIN VIROL, V77, P69, DOI 10.1016/j.jcv.2016.02.009
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   Marano G, 2016, BLOOD TRANSFUS-ITALY, V14, P95, DOI 10.2450/2015.0066-15
   Mlakar J, 2016, N ENGL J MED
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Patino-Barbosa AM, 2015, SEX TRANSM INFECT, V91, P359, DOI 10.1136/sextrans-2015-052189
   Rodríguez-Morales Alfonso J., 2016, Infect., V20, P59, DOI 10.1016/j.infect.2016.02.001
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P5, DOI 10.1016/j.tmaid.2016.01.011
   Rodriguez-Morales AJ, 2015, J INFECT DEV COUNTR, V9, P684, DOI 10.3855/jidc.7230
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
NR 20
TC 28
Z9 28
U1 0
U2 37
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1476-0711
J9 ANN CLIN MICROB ANTI
JI Ann. Clin. Microbiol. Antimicrob.
PD MAR 3
PY 2016
VL 15
AR 13
DI 10.1186/s12941-016-0128-2
PG 2
WC Microbiology
SC Microbiology
GA DF6IZ
UT WOS:000371460400001
PM 26939897
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Bandeira, AC
   Campos, GS
   Diniz Rocha, VF
   de Freitas Souza, BS
   Pereira Soares, MB
   Oliveira, AA
   de Abreu, YC
   Menezes, GS
   Sardi, SI
AF Bandeira, Antonio Carlos
   Campos, Gubio Soares
   Diniz Rocha, Veronica Franca
   de Freitas Souza, Bruno Solano
   Pereira Soares, Milena Botelho
   Oliveira, Alexsandro Araujo
   de Abreu, Yara Carvalho
   Menezes, Gabriela Sant'Ana
   Sardi, Silvia Ines
TI Prolonged shedding of Chikungunya virus in semen and urine: A new
   perspective for diagnosis and implications for transmission
SO IDCASES
LA English
DT Article
DE Chikungunya virus; Dual infection; Dengue virus; STD; Semen
ID ZIKA VIRUS; DENGUE VIRUSES; SEXUAL TRANSMISSION; EBOLA-VIRUS;
   COINFECTIONS; INFECTIONS; OUTBREAK; PATIENT; BAHIA
AB We report the presence of Chikungunya (CHIKV) RNA in the blood, urine and semen during the acute phase of the disease in an adult with a dual infection with Dengue virus type 3. The patient, a 25 yr-old man from Salvador, Brazil, reported a 6-day duration of high fever, arthralgia, myalgia, headache and photophobia.
   Blood and semen specimens were positive for CHIKV in the first collected samples; semen and urine specimens were positive for CHIKV after 30 days of symptoms onset. DENV-3 RNA was positive in blood specimen when first collected 6 days after the initiation of symptoms. We describe for the first time the presence of CHIKV RNA in urine and semen for an extended period of time and we address the possible implications of these findings for diagnosis and transmission dynamics. (C) 2016 The Authors. Published by Elsevier Ltd.
C1 [Bandeira, Antonio Carlos] Fac Tecnol & Ciencias Med Sch, Av Luis Viana,8812,RECOLZIKA, BR-41741590 Salvador, BA, Brazil.
   [Campos, Gubio Soares; Sardi, Silvia Ines] Univ Fed Bahia, Virol Lab, Salvador, BA, Brazil.
   [Diniz Rocha, Veronica Franca] Hosp Geral Roberto Santos, Infect Control Comm, Salvador, BA, Brazil.
   [de Freitas Souza, Bruno Solano] Fiocruz MS, Goncalo Moniz Inst, Salvador, BA, Brazil.
   [Pereira Soares, Milena Botelho] Sao Rafael Hosp, Ctr Biotechnol & Cell Therapy, Salvador, BA, Brazil.
   [Oliveira, Alexsandro Araujo] Univ Fed Bahia, Biotechnol Campus, Salvador, BA, Brazil.
   [de Abreu, Yara Carvalho; Menezes, Gabriela Sant'Ana] Univ Fed Bahia, Coll Pharm, Salvador, BA, Brazil.
RP Bandeira, AC (corresponding author), Fac Tecnol & Ciencias Med Sch, Av Luis Viana,8812,RECOLZIKA, BR-41741590 Salvador, BA, Brazil.
EM antoniobandeira@gmail.com; gubiosoares@gmail.com;
   veronica.diniz.rocha@gmail.com; bruno.souza@bahia.fiocruz.br;
   milena@bahia.fiocruz.br; alexaraoliveira@gmail.com;
   yara.c.abreu@hotmail.com; g.menezes@outlook.com; sissardi@yahoo.com.br
RI ; sardi, silvia ines/P-9349-2016
OI Soares, Milena/0000-0001-7549-2992; sardi, silvia
   ines/0000-0002-2002-8436
FU Ministry of Education Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior (CAPES) - ZIKA FASTRACK [88887-116628/2016]
FX This work was supported by the Ministry of Education Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES) - ZIKA FASTRACK
   NUMBER 88887-116628/2016.
CR Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Bandeira AC, 2016, IDCases, V5, P57, DOI 10.1016/j.idcr.2016.07.008
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.32.30316
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Chahar HS, 2009, EMERG INFECT DIS, V15, P1077, DOI 10.3201/eid1507.080638
   Chusri S, 2011, AM J TROP MED HYG, V85, P386, DOI 10.4269/ajtmh.2011.10-0725
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Deen GF, 2015, N ENGL J MED
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Edwards CJ, 2007, J CLIN VIROL, V39, P271, DOI 10.1016/j.jcv.2007.05.008
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Furuya-Kanamori L, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1417-2
   Gerardin P, 2008, PLOS MED, V5, P413, DOI 10.1371/journal.pmed.0050060
   Gimenes F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098862
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Luttmer R, 2015, FERTIL STERIL, V104, P838, DOI 10.1016/j.fertnstert.2015.06.028
   Mackay IM, 2015, LANCET INFECT DIS, V15, P149, DOI 10.1016/S1473-3099(14)71033-3
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   MARTINI GA, 1968, KLIN WOCHENSCHR, V46, P398, DOI 10.1007/BF01734141
   Mate SE, 2015, NEW ENGL J MED, V373, P2448, DOI 10.1056/NEJMoa1509773
   Musso D, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0556-9
   MYERS RM, 1967, SCIENCE, V157, P1307, DOI 10.1126/science.157.3794.1307
   Poo YS, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003354
   Ratsitorahina M, 2008, EMERG INFECT DIS, V14, P1135, DOI 10.3201/eid1407.071521
   Sardi SI, 2016, J CLIN MICROBIOL, V54, P2348, DOI 10.1128/JCM.00877-16
   Shaikh N, 2015, INDIAN J MED MICROBI, V33, P459, DOI 10.4103/0255-0857.158607
   Solignat M, 2009, VIROLOGY, V393, P183, DOI 10.1016/j.virol.2009.07.024
   Sourisseau M, 2007, PLOS PATHOG, V3, P804, DOI 10.1371/journal.ppat.0030089
   Uyeki TM, 2016, CLIN INFECT DIS, V62, P1552, DOI 10.1093/cid/ciw202
   van Duijl-Richter MKS, 2015, VIRUSES-BASEL, V7, P3647, DOI 10.3390/v7072792
   Villamil-Gomez WE, 2016, J INFECT PUBLIC HEAL, V9, P684, DOI 10.1016/j.jiph.2015.12.002
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
NR 39
TC 25
Z9 26
U1 0
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2214-2509
J9 IDCases
JI IDCases
PY 2016
VL 6
BP 100
EP 103
DI 10.1016/j.idcr.2016.10.007
PG 4
WC Infectious Diseases
SC Infectious Diseases
GA ER9MV
UT WOS:000399151400032
PM 27882301
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Bandeira, AC
   Campos, GS
   Sardi, SI
   Rocha, VFD
   Rocha, GCM
AF Bandeira, Antonio Carlos
   Campos, Gubio Soares
   Sardi, Silvia Ines
   Diniz Rocha, Veronica Franca
   Mendes Rocha, Guilherme Cesar
TI Neonatal encephalitis due to Chikungunya vertical transmission: First
   report in Brazil
SO IDCASES
LA English
DT Article
DE Chikungunya-associated encephalitis; Chikungunya neonatal; Neurological
   syndromes; Neonatal encephalitis; Vertical transmission
ID ZIKA VIRUS; INFECTION
AB Purpose: To report the first case of Chikungunya encephalitis acquired in the perinatal period during the current outbreak in Brazil
   Methods: Case report.
   Results: A male neonate with 3500 g developed macular erythematous rash, hypoactivity and fever progressing to generalized seizures. His mother had experienced a disseminated rash and fever before delivery. EEG showed diffuse slowing and cranial NMR was suggestive of encephalitis. Rt-PCR for Chikungunya virus (CHIKV) was positive in cerebrospinal fluid (CSF), blood, urine and saliva. The newborn was discharged home with neurological improvement.
   Conclusion: We report the first case of a perinatal CHIKV infection associated with a rapidly evolving encephalitis and an extensive dissemination of the virus as documented by positive rt-PCR results in CSF, blood, urine and saliva in the present outbreak in Brazil. In countries experiencing outbreaks of CHIKV infections, clinicians and neonatologists must be familiar with the possibility of the occurrence of neurologic complications and its possible consequences. (C) 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license.
C1 [Bandeira, Antonio Carlos] Sch Med, Fac Ciencias & Tecnol, Av Luis Viana 8812, Salvador, BA, Brazil.
   [Campos, Gubio Soares; Sardi, Silvia Ines] Univ Fed Bahia, Virol Lab, Salvador, BA, Brazil.
   [Diniz Rocha, Veronica Franca] Hosp Geral Roberto Santos, Salvador, BA, Brazil.
   [Mendes Rocha, Guilherme Cesar] Hosp Alianca, Salvador, BA, Brazil.
RP Bandeira, AC (corresponding author), Sch Med, Fac Ciencias & Tecnol, Av Luis Viana 8812, Salvador, BA, Brazil.
EM antoniobandeira@gmail.com; gubiosoares@gmail.com; sissardi@yahoo.com.br;
   veronica.diniz.rocha@gmail.com; guilhermecmrocha@uol.com.br
RI sardi, silvia ines/P-9349-2016
OI sardi, silvia ines/0000-0002-2002-8436
CR Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Casolari S, 2008, SCAND J INFECT DIS, V40, P995, DOI 10.1080/00365540802419055
   Chatterjee S N, 1965, J Indian Med Assoc, V45, P314
   Chusri S, 2011, AM J TROP MED HYG, V85, P386, DOI 10.4269/ajtmh.2011.10-0725
   Edwards CJ, 2007, J CLIN VIROL, V39, P271, DOI 10.1016/j.jcv.2007.05.008
   Ganesan K, 2008, AM J NEURORADIOL, V29, P1636, DOI 10.3174/ajnr.A1133
   Gauri L A, 2012, J Assoc Physicians India, V60, P68
   Gerardin P, 2014, PLOS NEGLECT TROP D, V8, P1, DOI DOI 10.1371/JOURNAL.PNTD.0002996&TYPE=PRINTABLE
   Gerardin P, 2016, NEUROLOGY, V86, P17, DOI 10.1212/WNL.0000000000002244
   Gerardin P, 2008, PLOS MED, V5, P413, DOI 10.1371/journal.pmed.0050060
   Ministerio da Saude (BR), 2014, PREP RESP INTR VIR C
   Pialoux G, 2006, MED MALADIES INFECT, V36, P253, DOI 10.1016/j.medmal.2006.04.002
   Robillard PY, 2006, PRESSE MED, V35, P785, DOI 10.1016/S0755-4982(06)74690-5
   Robin S, 2008, J CHILD NEUROL, V23, P1028, DOI 10.1177/0883073808314151
   Rodriguez-Morales AJ, 2016, ANN CLIN MICROB ANTI, V15, DOI 10.1186/s12941-016-0128-2
   Senanayake M. P., 2009, CEYLON MEDICAL JOURNAL, V54, P47
   Wilmer Villamil-Go'mez, 2015, J TROP PEDIATRICS, P1
NR 18
TC 27
Z9 27
U1 0
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2214-2509
J9 IDCases
JI IDCases
PY 2016
VL 5
BP 57
EP 59
DI 10.1016/j.idcr.2016.07.008
PG 3
WC Infectious Diseases
SC Infectious Diseases
GA ER9MP
UT WOS:000399150800019
PM 27500084
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Campos, GS
   Bandeira, AC
   Sardi, SI
AF Campos, Gubio S.
   Bandeira, Antonio C.
   Sardi, Silvia I.
TI Zika Virus Outbreak, Bahia, Brazil
SO EMERGING INFECTIOUS DISEASES
LA English
DT Letter
C1 [Campos, Gubio S.; Sardi, Silvia I.] Univ Fed Bahia, Salvador, BA, Brazil.
   [Bandeira, Antonio C.] Hosp Alianca, Salvador, BA, Brazil.
RP Sardi, SI (corresponding author), Univ Fed Bahia, Inst Ciencias Saude, Virol Lab, Av Reitor Miguel Calmon,S-N 40110-100 Vale Canela, Salvador, BA, Brazil.
EM sissardi@yahoo.com.br
RI sardi, silvia ines/P-9349-2016
OI sardi, silvia ines/0000-0002-2002-8436
CR Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Chowdhury P, 2014, COMP IMMUNOL MICROB, V37, P39, DOI 10.1016/j.cimid.2013.10.006
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Edwards CJ, 2007, J CLIN VIROL, V39, P271, DOI 10.1016/j.jcv.2007.05.008
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Mourao MPG, 2012, VECTOR-BORNE ZOONOT, V12, P42, DOI 10.1089/vbz.2011.0669
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
NR 10
TC 634
Z9 659
U1 1
U2 248
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD OCT
PY 2015
VL 21
IS 10
BP 1885
EP 1886
DI 10.3201/eid2110.150847
PG 2
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA CS5ZY
UT WOS:000362158000038
PM 26401719
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Campos, GS
   Pinho, ACO
   Brandao, CJD
   Bandeira, AC
   Sardi, SI
AF Campos, Gubio Soares
   Oliveira Pinho, Aryane Cruz
   de Freitas Brandao, Claudio Jose
   Bandeira, Antonio Carlos
   Sardi, Silvia Ines
TI Dengue Virus 4 (DENV-4) Re-Emerges after 30 Years in Brazil:
   Cocirculation of DENV-2, DENV-3, and DENV-4 in Bahia
SO JAPANESE JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
ID NONSTRUCTURAL PROTEIN-1; DIAGNOSTIC-ACCURACY; HEMORRHAGIC-FEVER; DISEASE
   SEVERITY; VIRAL LOAD; INFECTION; NS1; ANTIGEN; TESTS; SPECIFICITY
AB Dengue fever (DF) is a mosquito-borne viral disease of great concern in tropical and subtropical regions of the world. One important cause of the increase in DF is rapid development and urbanization has led to proliferation of the Aedes aegypti mosquito, the vector responsible for transmission of the illness. Surveillance of dengue virus (DENY) infection in Brazil shows the predominance of DENV-1, DENV-2, and DENV-3 until 2010. This study reports the reappearance of DENV-4 in Brazil for the first time in 30 years. Serum samples were collected from individuals (n = 214) exhibiting fever and muscular pain in Bahia, Brazil, during 2011-2012. These samples were subjected to reverse transcription-polymerase chain reaction (RT-PCR)/nested PCR, which revealed that 82% of samples were positive for DENV-4; most were older age groups and exhibited a serological pattern consistent with a primary infection. The cocirculation of multiple DENY serotypes within the same city places the population at risk for a fatal form of the disease. Therefore, with the increasing incidence of severe DF cases, early diagnosis will be a priority for public health efforts in Brazil.
C1 [Campos, Gubio Soares; Oliveira Pinho, Aryane Cruz; Sardi, Silvia Ines] Univ Fed Bahia, Hlth Sci Inst, Virol Lab, Dept Biointeract, Salvador, Brazil.
   [de Freitas Brandao, Claudio Jose; Bandeira, Antonio Carlos] Hosp Alianca, Salvador, BA, Brazil.
RP Sardi, SI (corresponding author), Univ Fed Bahia, Inst Ciencias Saude, Virol Lab, Av Reitor Miguel Calmon S-N, BR-40110100 Vale Do Canela Salvador, BA, Brazil.
EM sissardi@yahoo.com.br
RI sardi, silvia ines/P-9349-2016
OI sardi, silvia ines/0000-0002-2002-8436
FU Hospital Alianca, Salvador, Bahia; FAPESB
FX We thank the clinicians from Hospital Alianca, Salvador, Bahia and
   FAPESB for financial support.
CR Blacksell SD, 2012, CLIN VACCINE IMMUNOL, V19, P804, DOI 10.1128/CVI.05717-11
   Clyde K, 2006, J VIROL, V80, P11418, DOI 10.1128/JVI.01257-06
   Duong V, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001244
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   Hang VT, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000360
   Hu DM, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-47
   Hunsperger EA, 2009, EMERG INFECT DIS, V15, P436, DOI 10.3201/eid1503.080923
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Libraty DH, 2002, J INFECT DIS, V186, P1165, DOI 10.1086/343813
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Mathew A, 2011, J INFECT DIS, V204, P1514, DOI 10.1093/infdis/jir607
   Muller DA, 2012, J GEN VIROL, V93, P771, DOI 10.1099/vir.0.039321-0
   Osorio L, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-361
   Poersch CD, 2005, J CLIN VIROL, V32, P272, DOI 10.1016/j.jcv.2004.08.008
   Melo MSS, 2010, REV SOC BRAS MED TRO, V43, P139, DOI 10.1590/S0037-86822010000200007
   Thai KTD, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001180
   Thomas L, 2008, AM J TROP MED HYG, V78, P990
   Thrusfield M., 2000, VET EPIDEMIOLOGY, P266
   Tricou V, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-142
   Vaughn DW, 2000, J INFECT DIS, V181, P2, DOI 10.1086/315215
   Wang SM, 2010, AM J TROP MED HYG, V83, P690, DOI 10.4269/ajtmh.2010.10-0117
   Wang WK, 2006, CLIN INFECT DIS, V43, P1023, DOI 10.1086/507635
   World Health Organization, 2009, DENG GUID DIAGN TREA
   Young PR, 2000, J CLIN MICROBIOL, V38, P1053, DOI 10.1128/JCM.38.3.1053-1057.2000
   Zompi S, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001568
NR 26
TC 3
Z9 3
U1 0
U2 12
PU NATL INST INFECTIOUS DISEASES
PI TOKYO
PA JPN J INFECT DIS ED OFF NATL INST INFECTIOUS DISEASES TOYAMA 1-23-1,
   SHINJUKU-KU, TOKYO, 162-8640, JAPAN
SN 1344-6304
EI 1884-2836
J9 JPN J INFECT DIS
JI Jpn. J. Infect. Dis.
PD JAN
PY 2015
VL 68
IS 1
BP 45
EP 49
DI 10.7883/yoken.JJID.2014.063
PG 5
WC Infectious Diseases
SC Infectious Diseases
GA CA3RW
UT WOS:000348824800009
PM 25420650
OA Bronze
DA 2020-12-01
ER

PT J
AU Amado, IF
   Berges, J
   Luther, RJ
   Mailhe, MP
   Garcia, S
   Bandeira, A
   Weaver, C
   Liston, A
   Freitas, AA
AF Amado, Ines F.
   Berges, Julien
   Luther, Rita J.
   Mailhe, Marie-Pierre
   Garcia, Sylvie
   Bandeira, Antonio
   Weaver, Casey
   Liston, Adrian
   Freitas, Antonio A.
TI IL-2 coordinates IL-2 producing and regulatory T cell interplay
SO CYTOKINE
LA English
DT Meeting Abstract
CT 2nd Annual Meeting of the International-Cytokine-and-Interferon-Society
   (ICIS)
CY OCT 26-29, 2014
CL Melbourne, AUSTRALIA
SP Int Cytokine & Interferon Soc
C1 [Amado, Ines F.; Berges, Julien; Mailhe, Marie-Pierre; Garcia, Sylvie; Bandeira, Antonio; Freitas, Antonio A.] Inst Pasteur, Paris, France.
   [Luther, Rita J.; Weaver, Casey] Univ Alabama Birmingham, Birmingham, AL USA.
   [Liston, Adrian] Univ Leuven, Leuven, Belgium.
RI Liston, Adrian/G-8606-2013
OI Liston, Adrian/0000-0002-6272-4085
NR 0
TC 0
Z9 0
U1 0
U2 3
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 1043-4666
EI 1096-0023
J9 CYTOKINE
JI Cytokine
PD NOV
PY 2014
VL 70
IS 1
MA 48
BP 39
EP 39
DI 10.1016/j.cyto.2014.07.055
PG 1
WC Biochemistry & Molecular Biology; Cell Biology; Immunology
SC Biochemistry & Molecular Biology; Cell Biology; Immunology
GA AQ7TI
UT WOS:000343021700078
DA 2020-12-01
ER

PT J
AU Laur, A
   Chrisment, D
   Korolik, V
   Floch, P
   Chambonnier, L
   Benejat, L
   Gauthereau, X
   Giese, A
   Capellen, D
   Idrissi, Y
   Dubus, P
   Bandeira, A
   Megraud, F
   Lehours, P
AF Laur, A.
   Chrisment, D.
   Korolik, V.
   Floch, P.
   Chambonnier, L.
   Benejat, L.
   Gauthereau, X.
   Giese, A.
   Capellen, D.
   Idrissi, Y.
   Dubus, P.
   Bandeira, A.
   Megraud, F.
   Lehours, P.
TI INFLAMMATORY RESPONSE IN NEONATAL THYMECTOMIZED BALB/C MICE INFECTED BY
   HELICOBACTER PYLORI STRAINS
SO HELICOBACTER
LA English
DT Meeting Abstract
CT European-Helicobacter-Study-Group 27th International Workshop on
   Helicobacter and Microbiota in Chronic Digestive Inflammation and
   Gastric Cancer
CY SEP 11-13, 2014
CL Rome, ITALY
SP European Helicobacter Study Grp
C1 [Laur, A.; Chrisment, D.; Floch, P.; Chambonnier, L.; Benejat, L.; Megraud, F.; Lehours, P.] Univ Bordeaux, INSERM, U853, Bordeaux, France.
   [Korolik, V.] Griffith Univ, Inst Glyc, Gold Coast, Australia.
   [Gauthereau, X.] CIRID, UMR 5164, Bordeaux, France.
   [Giese, A.; Capellen, D.; Idrissi, Y.; Dubus, P.] Univ Bordeaux, EA 2406, Bordeaux, France.
   [Bandeira, A.] Inst Pasteur, INSERM, Unite Lymphopoiese, U668, F-75724 Paris, France.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1083-4389
EI 1523-5378
J9 HELICOBACTER
JI Helicobacter
PD SEP
PY 2014
VL 19
SU 1
SI SI
MA W4.1
BP 83
EP 83
PG 1
WC Gastroenterology & Hepatology; Microbiology
SC Gastroenterology & Hepatology; Microbiology
GA AO8SG
UT WOS:000341623900031
DA 2020-12-01
ER

PT J
AU Guy-Grand, D
   Vassalli, P
   Eberl, G
   Pereira, P
   Burlen-Defranoux, O
   Lemaitre, F
   Di Santo, JP
   Freitas, AA
   Cumano, A
   Bandeira, A
AF Guy-Grand, Delphine
   Vassalli, Pierre
   Eberl, Gerard
   Pereira, Pablo
   Burlen-Defranoux, Odile
   Lemaitre, Fabrice
   Di Santo, James P.
   Freitas, Antonio A.
   Cumano, Ana
   Bandeira, Antonio
TI Origin, trafficking, and intraepithelial fate of gut-tropic T cells (vol
   210, pg 1839, 2013)
SO JOURNAL OF EXPERIMENTAL MEDICINE
LA English
DT Correction
RI Eberl, Gerard/A-1160-2013; VOUGNY, Marie-Christine/K-8938-2017; freitas,
   antonio/A-2482-2013; Di Santo, James P/M-4298-2014
OI Di Santo, James P/0000-0002-7146-1862
CR Guy-Grand D, 2013, J EXP MED, V210, P1839, DOI 10.1084/jem.20122588
NR 1
TC 1
Z9 1
U1 0
U2 4
PU ROCKEFELLER UNIV PRESS
PI NEW YORK
PA 1114 FIRST AVE, 4TH FL, NEW YORK, NY 10021 USA
SN 0022-1007
EI 1540-9538
J9 J EXP MED
JI J. Exp. Med.
PD OCT 21
PY 2013
VL 210
IS 11
BP 2493
EP 2493
DI 10.1084/jem.20122588104c
PG 1
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA 239BX
UT WOS:000325997600025
OA Green Published, Green Accepted, Bronze
DA 2020-12-01
ER

PT J
AU Carpentier, M
   Chappert, P
   Kuhn, C
   Lalfer, M
   Flament, H
   Burlen-Defranoux, O
   Lantz, O
   Bandeira, A
   Malissen, B
   Davoust, J
   Gross, DA
AF Carpentier, Maxime
   Chappert, Pascal
   Kuhn, Chantal
   Lalfer, Melanie
   Flament, Heloise
   Burlen-Defranoux, Odile
   Lantz, Olivier
   Bandeira, Antonio
   Malissen, Bernard
   Davoust, Jean
   Gross, David-Alexandre
TI Extrathymic induction of Foxp3(+) regulatory T cells declines with age
   in a T-cell intrinsic manner
SO EUROPEAN JOURNAL OF IMMUNOLOGY
LA English
DT Article
DE Aging; Foxp3; Regulatory T (Treg) cells; Transplantation
ID RECENT THYMIC EMIGRANTS; TOLERANCE; MICE; CYTOKINES; INFLAMMATION;
   GENERATION; COLITIS; ANTIGEN
AB Extrathymically induced Foxp3(+) regulatory T (Treg) cells contribute to the pool of Treg cells and are implicated in the maintenance of immune tolerance at environmental interfaces. The impact of T-cell senescence on their generation and function is, however, poorly characterized. We report here that steady-state induction of Foxp3 is impaired in aged T cells in vivo. In vitro assays further revealed that this defective generation of Treg cells was independent from the strength of TCR stimulation and arose before T-cell proliferation. Importantly, they also revealed that this impairment of Foxp3 induction is unrelated to known age-related T-cell defects, such as IL-2 secretion impairment, accumulation of activated T-cell populations, or narrowing of the T-cell repertoire. Finally, a loss of extrathymic induction of Foxp3 and tolerance to minor-mismatched skin graft were observed in aged mice treated by nondepleting anti-CD4 antibody. The T-cell intrinsic impairment of Treg-cell generation revealed here highlights age as a key factor to be considered in immune tolerance induction.
C1 [Carpentier, Maxime; Chappert, Pascal; Kuhn, Chantal; Lalfer, Melanie; Davoust, Jean; Gross, David-Alexandre] Univ Paris 05, Fac Med, Inst Natl Sante & Rech Med, Sorbonne Paris Cite,U1013, F-75743 Paris 15, France.
   [Flament, Heloise; Lantz, Olivier] Inst Curie, Lab Immunol, Paris, France.
   [Flament, Heloise; Lantz, Olivier] Inst Curie, Inst Natl Sante & Rech Med, U932, Paris, France.
   [Burlen-Defranoux, Odile] Inst Pasteur, INSERM, U668, Unite Lymphopoiese, F-75724 Paris, France.
   [Bandeira, Antonio] Inst Pasteur, CNRS, URA 1961, Unite Biol Populat Lymphocytaires, Paris, France.
   [Malissen, Bernard] Aix Marseille Univ, INSERM, U1104, CNRS,CIML,UMR7280, Marseille, France.
RP Gross, DA (corresponding author), Univ Paris 05, Hop Necker Enfants Malad, Inst Natl Sante & Rech Med, Sorbonne Paris Cite,Fac Med,U1013, 161 Rue Sevres, F-75743 Paris 15, France.
EM jean.davoust@inserm.fr; david.gross@inserm.fr
RI Gross, David A/N-7521-2017; Malissen, Bernard/AAK-4659-2020; Davoust,
   Jean/ABB-6720-2020
OI Gross, David A/0000-0001-6688-9816; Malissen,
   Bernard/0000-0003-1340-9342; Bandeira Ferreira,
   Antonio/0000-0002-8054-8716; Davoust, Jean/0000-0002-3098-7665; Lantz,
   olivier/0000-0003-3161-7719; Flament, Heloise/0000-0002-5443-4117;
   chappert, pascal/0000-0002-9799-4608
FU Association Francaise contre les MyopathiesAssociation Francaise contre
   les Myopathies; Agence Nationale de la RechercheFrench National Research
   Agency (ANR) [ANR-11-JSV3]; French Ministry of ResearchMinistry of
   Research, France; Fondation pour la Recherche Medicale (FRM)Fondation
   pour la Recherche Medicale
FX We thank Stephen Cobbold for the kind gift of YTS 177.4 antibody,
   Corinne Cordier and Jerome Megret for cell sorting. This work was
   supported by the Association Francaise contre les Myopathies and the
   Agence Nationale de la Recherche (ANR-11-JSV3). M. Carpentier, P.
   Chappert, and M. Lalfer were supported by the French Ministry of
   Research. C. Kuhn was supported by the Fondation pour la Recherche
   Medicale (FRM).
CR Bhaumik S, 2013, J IMMUNOL, V190, P2603, DOI 10.4049/jimmunol.1200852
   Blackman MA, 2011, CURR OPIN IMMUNOL, V23, P537, DOI 10.1016/j.coi.2011.05.005
   Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152
   Chougnet CA, 2011, J IMMUNOL, V186, P156, DOI 10.4049/jimmunol.1001505
   den Braber I, 2012, IMMUNITY, V36, P288, DOI 10.1016/j.immuni.2012.02.006
   Desai A, 2010, J LEUKOCYTE BIOL, V87, P1001, DOI 10.1189/jlb.0809542
   Eaton SM, 2004, J EXP MED, V200, P1613, DOI 10.1084/jem.20041395
   Gabrysova L, 2011, EUR J IMMUNOL, V41, P1242, DOI 10.1002/eji.201041073
   Gottschalk RA, 2010, J EXP MED, V207, P1701, DOI 10.1084/jem.20091999
   Gross DA, 2006, BLOOD, V108, P1841, DOI 10.1182/blood-2006-02-011981
   Haribhai D, 2009, J IMMUNOL, V182, P3461, DOI 10.4049/jimmunol.0802535
   Haynes L, 1999, J EXP MED, V190, P1013, DOI 10.1084/jem.190.7.1013
   Haynes L, 2009, CURR OPIN IMMUNOL, V21, P414, DOI 10.1016/j.coi.2009.05.009
   Hill JA, 2008, IMMUNITY, V29, P758, DOI 10.1016/j.immuni.2008.09.018
   Huang MC, 2008, FASEB J, V22, P2142, DOI 10.1096/fj.07-103721
   Josefowicz SZ, 2012, NATURE, V482, P395, DOI 10.1038/nature10772
   Kendal AR, 2011, J EXP MED, V208, P2043, DOI 10.1084/jem.20110767
   Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428
   Lahl K, 2007, J EXP MED, V204, P57, DOI 10.1084/jem.20061852
   Lathrop SK, 2008, J EXP MED, V205, P3105, DOI 10.1084/jem.20081359
   Macaulay R, 2013, AGE, V35, P563, DOI 10.1007/s11357-012-9381-2
   Mucida D, 2005, J CLIN INVEST, V115, P1923, DOI 10.1172/JCI24487
   Oliveira VG, 2011, EUR J IMMUNOL, V41, P1249, DOI 10.1002/eji.201040896
   Ouyang XS, 2011, CELL IMMUNOL, V266, P208, DOI 10.1016/j.cellimm.2010.10.007
   Paiva RS, 2013, P NATL ACAD SCI USA, V110, P6494, DOI 10.1073/pnas.1221955110
   Regateiro FS, 2012, J IMMUNOL, V189, P3947, DOI 10.4049/jimmunol.1200449
   Rowe JH, 2012, NATURE, V490, P102, DOI 10.1038/nature11462
   Samstein RM, 2012, CELL, V150, P29, DOI 10.1016/j.cell.2012.05.031
   Tischner D, 2012, J AUTOIMMUN, V38, P59, DOI 10.1016/j.jaut.2011.12.008
   Wang Y, 2008, J IMMUNOL, V180, P1565, DOI 10.4049/jimmunol.180.3.1565
NR 30
TC 11
Z9 12
U1 0
U2 13
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0014-2980
EI 1521-4141
J9 EUR J IMMUNOL
JI Eur. J. Immunol.
PD OCT
PY 2013
VL 43
IS 10
BP 2598
EP 2604
DI 10.1002/eji.201343532
PG 7
WC Immunology
SC Immunology
GA 282FH
UT WOS:000329155200010
PM 23824593
OA Bronze
DA 2020-12-01
ER

PT J
AU Colombo, AL
   Garnica, M
   Camargo, LFA
   Da Cunha, CA
   Bandeira, AC
   Borghi, D
   Campos, T
   Senna, AL
   Didier, MEV
   Dias, VC
   Nucci, M
AF Colombo, Arnaldo L.
   Garnica, Marcia
   Aranha Camargo, Luis Fernando
   Da Cunha, Clovis Arns
   Bandeira, Antonio Carlos
   Borghi, Danielle
   Campos, Tatiana
   Senna, Ana Lucia
   Valias Didier, Maria Eugenia
   Dias, Viviane Carvalho
   Nucci, Marcio
TI Candida glabrata: an emerging pathogen in Brazilian tertiary care
   hospitals
SO MEDICAL MYCOLOGY
LA English
DT Article
DE Candida glabrata; emergent fungal pathogen; fluconazole resistance;
   epidemiology
ID RESOURCE UTILIZATION; ANTIFUNGAL THERAPY; EPIDEMIOLOGY; SURVEILLANCE;
   INFECTIONS; PREDICTORS; NATIONWIDE; AMERICA; DEATH
AB Candida glabrata is an infrequent cause of candidemia in Brazilian public hospitals. We investigated putative differences in the epidemiology of candidemia in institutions with different sources of funding. Prospective laboratory-based surveillance of candidemia was conducted in seven private and two public Brazilian tertiary care hospitals. Among 4,363 episodes of bloodstream infection, 300 were caused by Candida spp. (6.9%). Incidence rates were significantly higher in public hospitals, i.e., 2.42 vs. 0.91 episodes per 1,000 admissions (P < 0.01). Patients in private hospitals were older, more likely to be in an intensive care unit and to have been exposed to fluconazole before candidemia. Candida parapsilosis was more frequently recovered as the etiologic agent in public (33% vs. 16%, P < 0.001) hospitals, whereas C. glabrata was more frequently isolated in private hospitals (13% vs. 3%, P < 0.001). Fluconazole resistance among C. glabrata isolates was more frequent in private hospitals (76.5% vs. 20%, P = 0.02). The 30-day mortality was slightly higher among patients in public hospitals (53% vs. 43%, P = 0.10). Candida glabrata is an emerging pathogen in private institutions and in this setting, fluconazole should not be considered as a safe option for primary therapy of candidemia.
C1 [Garnica, Marcia; Nucci, Marcio] Univ Fed Rio de Janeiro, Univ Hosp, Rio De Janeiro, Brazil.
   [Aranha Camargo, Luis Fernando] Hosp Israelita Albert Einstein, Sao Paulo, Brazil.
   [Da Cunha, Clovis Arns; Dias, Viviane Carvalho] Hosp Nossa Senhora Gracas, Curitiba, Parana, Brazil.
   [Bandeira, Antonio Carlos] Hosp Alianca, Salvador, BA, Brazil.
   [Borghi, Danielle] Hosp Copa DOr, Rio De Janeiro, Brazil.
   [Campos, Tatiana] Hosp Barra DOr, Rio De Janeiro, Brazil.
   [Senna, Ana Lucia] Hosp Quinta DOr, Rio De Janeiro, Brazil.
   [Valias Didier, Maria Eugenia; Dias, Viviane Carvalho] Hosp Felicio Rocho, Belo Horizonte, MG, Brazil.
   [Colombo, Arnaldo L.] Univ Fed Sao Paulo, Sao Paulo, Brazil.
RP Colombo, AL (corresponding author), Univ Fed Sao Paulo, Escola Paulista Med, Div Infect Dis, Hosp Sao Paulo, Rua Botucatu 740, Sao Paulo, Brazil.
EM colomboal@terra.com.br
RI Colombo, Arnaldo Lopes/V-4417-2019; Nucci, Marcio/G-4515-2012; Garnica,
   Marcia/D-5854-2013; Colombo, Arnaldo Lopes/H-4397-2012
OI Nucci, Marcio/0000-0003-4867-0014; Garnica, Marcia/0000-0003-1067-6680;
   Camargo, Luis Fernando Aranha/0000-0002-3888-8661; Colombo, Arnaldo
   Lopes/0000-0003-0793-8491
FU United Medical; GileadGilead Sciences
FX We are very grateful to United Medical and Gilead that provided
   unconditional funding to partially support this study.
CR Arnold HM, 2010, PHARMACOTHERAPY, V30, P361, DOI 10.1592/phco.30.4.361
   Asmundsdottir LR, 2002, J CLIN MICROBIOL, V40, P3489, DOI 10.1128/JCM.40.9.3489-3492.2002
   Clinical and Laboratory Standards Institute, 2008, M27A3 CLIN LAB STAND
   Colombo AL, 2007, INFECT CONT HOSP EP, V28, P570, DOI 10.1086/513615
   Colombo AL, 2006, J CLIN MICROBIOL, V44, P2816, DOI 10.1128/JCM.00773-06
   Horn DL, 2009, CLIN INFECT DIS, V48, P1695, DOI 10.1086/599039
   Leroy O, 2009, CRIT CARE MED, V37, P1612, DOI 10.1097/CCM.0b013e31819efac0
   Lloyd-Sherlock P, 2000, SOC SCI MED, V51, P887, DOI 10.1016/S0277-9536(00)00068-X
   Nguyen MH, 1998, J INFECT DIS, V177, P425, DOI 10.1086/514193
   Nucci M, 2010, CLIN INFECT DIS, V51, P561, DOI 10.1086/655683
   Pasqualotto AC, 2008, INFECT CONT HOSP EP, V29, P898, DOI 10.1086/590191
   Pfaller MA, 2010, DRUG RESIST UPDATE, V13, P180, DOI 10.1016/j.drup.2010.09.002
   Pfaller MA, 2010, DIAGN MICR INFEC DIS, V67, P162, DOI 10.1016/j.diagmicrobio.2010.01.002
   Rodriguez D, 2010, CLIN MICROBIOL INFEC, V16, P1676, DOI 10.1111/j.1469-0691.2010.03208.x
   Shaw AB, 1996, DRUG AGING, V9, P403, DOI 10.2165/00002512-199609060-00003
   Slavin MA, 2010, J ANTIMICROB CHEMOTH, V65, P1042, DOI 10.1093/jac/dkq053
   Wunsch H, 2008, CRIT CARE MED, V36, P2787, DOI 10.1097/CCM.0b013e318186aec8
   Zilberberg MD, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-150
NR 18
TC 35
Z9 35
U1 0
U2 9
PU INFORMA HEALTHCARE
PI LONDON
PA TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND
SN 1369-3786
J9 MED MYCOL
JI Med. Mycol.
PD JAN
PY 2013
VL 51
IS 1
BP 38
EP 44
DI 10.3109/13693786.2012.698024
PG 7
WC Infectious Diseases; Mycology; Veterinary Sciences
SC Infectious Diseases; Mycology; Veterinary Sciences
GA 052UG
UT WOS:000312223400005
PM 22762208
OA Bronze
DA 2020-12-01
ER

PT J
AU Bandeira, AC
   Barberino, MG
   Barreiro, K
   Campos, C
AF Bandeira, A. C.
   Barberino, M. G.
   Barreiro, K.
   Campos, C.
TI Prospective Study of Candida sp Bloodstream Infection Rates and
   Susceptibility Profile in a Tertiary Hospital in Salvador, Brazil:
   2003-2007
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Meeting Abstract
C1 [Bandeira, A. C.; Barberino, M. G.; Barreiro, K.; Campos, C.] Hosp Alianca, Salvador, BA, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD DEC
PY 2008
VL 12
BP E372
EP E372
DI 10.1016/j.ijid.2008.05.985
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA 406II
UT WOS:000263287800930
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Campos, GS
   Moreau, VH
   Bandeira, A
   Barberino, G
   Almeida, PF
   Amador, DM
   de Lima, MO
   Sardi, SI
AF Campos, Gubio Soares
   Moreau, Vitor Hugo
   Bandeira, Antonio
   Barberino, Goreth
   Almeida, Paulo Fernando
   Amador, David Moraga
   de Lima, Margareth Oliveira
   Sardi, Silvia Ines
TI Molecular detection and genetic diversity of norovirus in hospitalized
   young adults with acute gastroenteritis in Bahia, Brazil
SO ARCHIVES OF VIROLOGY
LA English
DT Article
ID ROUND-STRUCTURED VIRUSES; NORWALK-LIKE VIRUSES; RIO-DE-JANEIRO;
   UNITED-STATES; OUTBREAKS; EPIDEMIOLOGY; CHILDREN; RECOMBINATION;
   NETHERLANDS; INFECTIONS
AB The molecular epidemiology of a recent norovirus (NoV) outbreak in Brazil performed by comparative analysis with Genebank NoV sequences showed that the GII.4 strain was responsible for 72.5% of all NoV-positive cases (58/80). Other detected NoV strains included GII.3 (7/80; 8.8%) and GII.9 (8/80; 10%). This is the first outbreak reported in Bahia state, Brazil, during June-July of 2006, where NoV was identified as the principal etiologic agent in hospitalized young adults with acute gastroenteritis symptoms. These findings suggest that GII.4 is a predominant circulating genotype in NoV outbreaks in Brazil.
C1 [Campos, Gubio Soares; de Lima, Margareth Oliveira; Sardi, Silvia Ines] Univ Fed Bahia, Virol Lab, Dept Biointeract, Inst Hlth Sci, BR-40110100 Salvador, BA, Brazil.
   [Moreau, Vitor Hugo] Fac Ciencias & Tecnol, BR-41741590 Salvador, BA, Brazil.
   [Bandeira, Antonio; Barberino, Goreth] Alianca Hosp, BR-2096 Salvador, BA, Brazil.
   [Almeida, Paulo Fernando] Univ Fed Bahia, Labem Dept Biointeract, Inst Hlth Sci, BR-40110100 Salvador, BA, Brazil.
   [Amador, David Moraga] Univ Florida, Interdisciplinary Ctr Biotechnol Res, Gainesville, FL 32610 USA.
RP Sardi, SI (corresponding author), Univ Fed Bahia, Virol Lab, Dept Biointeract, Inst Hlth Sci, Av Reitor Miguel Calmon S-N, BR-40110100 Salvador, BA, Brazil.
EM sissardi@yahoo.com.br
RI Moreau, Vitor Hugo/J-4829-2015; Almeida, Paulo/F-4057-2012; Moreau,
   Vitor Hugo/B-8865-2009; sardi, silvia ines/P-9349-2016
OI Moreau, Vitor Hugo/0000-0002-5393-0645; Almeida,
   Paulo/0000-0003-3004-6272; sardi, silvia ines/0000-0002-2002-8436
CR Ambert-Balay K, 2005, J CLIN MICROBIOL, V43, P5179, DOI 10.1128/JCM.43.10.5179-5186.2005
   Blanton LH, 2006, J INFECT DIS, V193, P413, DOI 10.1086/499315
   Bull RA, 2007, J GEN VIROL, V88, P3347, DOI 10.1099/vir.0.83321-0
   CAMPOS GS, 2002, J MED BIOL, V1, P7
   Castilho JG, 2006, J CLIN MICROBIOL, V44, P3947, DOI 10.1128/JCM.00279-06
   Chapin AR, 2005, J CLIN MICROBIOL, V43, P1112, DOI 10.1128/JCM.43.3.1112-1117.2005
   Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500
   Fankhauser RL, 1998, J INFECT DIS, V178, P1571, DOI 10.1086/314525
   Felsenstein J, 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X
   Gallimore CI, 2004, BRAZ J MED BIOL RES, V37, P321, DOI 10.1590/S0100-879X2004000300005
   Green KY, 2007, FIELDS VIROLOGY
   Guerrant R. L., 1990, REV INFECT DIS, V12, P41
   Hale A, 2000, J MED VIROL, V62, P99, DOI 10.1002/1096-9071(200009)62:1&lt;99::AID-JMV15&gt;3.0.CO;2-0
   Hutson AM, 2004, TRENDS MICROBIOL, V12, P279, DOI 10.1016/j.tim.2004.04.005
   Koek AG, 2006, J CLIN VIROL, V35, P167, DOI 10.1016/j.jcv.2005.05.014
   Lamhoujeb S, 2007, CAN J MICROBIOL, V53, P1133, DOI 10.1139/W07-079
   Lopman B, 2004, LANCET, V363, P682, DOI 10.1016/S0140-6736(04)15641-9
   Mattner F, 2006, CLIN MICROBIOL INFEC, V12, P69, DOI 10.1111/j.1469-0691.2005.01299.x
   Parashar UD, 2003, B WORLD HEALTH ORGAN, V81, P236
   Parks CG, 1999, J MED VIROL, V58, P426, DOI 10.1002/(SICI)1096-9071(199908)58:4&lt;426::AID-JMV17&gt;3.0.CO;2-K
   Phan TG, 2006, J MED VIROL, V78, P971, DOI 10.1002/jmv.20649
   Santos N, 2005, J CLIN MICROBIOL, V43, P4064, DOI 10.1128/JCM.43.8.4064-4069.2005
   Schreier E, 2000, ARCH VIROL, V145, P443, DOI 10.1007/s007050050038
   Thackray LB, 2007, J VIROL, V81, P10460, DOI 10.1128/JVI.00783-07
   Victoria M, 2007, PEDIATR INFECT DIS J, V26, P602, DOI 10.1097/INF.0b013e3180618bea
   Vidal R, 2006, J CLIN MICROBIOL, V44, P2271, DOI 10.1128/JCM.01890-05
   Vinje J, 1996, J INFECT DIS, V174, P610, DOI 10.1093/infdis/174.3.610
   Waters A, 2007, VIROLOGY, V363, P11, DOI 10.1016/j.virol.2007.03.012
NR 28
TC 13
Z9 14
U1 0
U2 2
PU SPRINGER WIEN
PI WIEN
PA SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA
SN 0304-8608
J9 ARCH VIROL
JI Arch. Virol.
PD JUN
PY 2008
VL 153
IS 6
BP 1125
EP 1129
DI 10.1007/s00705-008-0078-x
PG 5
WC Virology
SC Virology
GA 304DA
UT WOS:000256089000013
PM 18392770
DA 2020-12-01
ER

PT J
AU Cairo, RC
   Silva, LR
   de Andrade, CF
   Barberino, MGD
   Bandeira, AC
   Santos, KP
   Diniz-Santos, DR
AF Cairo, Romilda Castro
   Silva, Luciana Rodrigues
   de Andrade, Carol Ferreira
   de Andrade Barberino, Maria Goreth
   Bandeira, Antonio Carlos
   Santos, Kleber Pimentel
   Diniz-Santos, Daniel R.
TI Bacterial contamination in milk kitchens in pediatric hospitals in
   Salvador, Brazil
SO BRAZILIAN JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE bacteria; microflora; hands; faeces; pharynx; milk; contamination;
   hospital; children
ID FOOD
AB Milk may represent an important source of infectious agents to hospitalized pediatric patients. To describe the bacterial microflora isolated from the hands, stools, pharynx of all workers at milk kitchens in pediatric hospitals in the city of Salvador, Brazil, as well as in the formulas prepared by them, we carried out this cross-sectional study with all 91 workers from the 20 milk kitchens of all the public and private hospitals in Salvador, Brazil. Hand and pharynx swabs and stool samples were collected from all workers, as well as samples of the milk and formulas delivered by the kitchens. All samples were cultured for the detection of pathogenic and non-pathogenic bacteria. Pathogenic bacteria were isolated from 20 (22.0%) and 8 (8.8%) cultures of the hands and pharynx of the workers, respectively. No pathogenic bacteria were isolated from stool samples. Pathogenic bacteria were isolated from 17 (18.7%) milk samples. The prevalence of pathogenic bacteria in hand swabs was significantly higher in workers from public (37.8%) than from private (6.5%) hospitals (prevalence ratio [PR]=5.8; p < 0.01). Pathogenic bacteria were isolated from two (4.4%) workers from public hospitals and six (13.0%) workers from private hospitals (PR=0.38; p=0.27). Pathogenic bacteria were isolated from 11 (24.4%) milk samples from public hospitals and 6 (13.0%) from private hospitals (PR=1.9; p=0.16). A high prevalence of contamination was found, mainly on the hands of workers on units for manipulation of milk. Preventive efforts should be intensified and focus primarily on effective hand washing and continuous work supervision.
C1 [Cairo, Romilda Castro; Silva, Luciana Rodrigues; de Andrade, Carol Ferreira; Diniz-Santos, Daniel R.] Univ Fed Bahia, Prof Hosannah Oliveira Pediat Ctr, Pediat Gastroenterol & Hepatol Serv, Salvador, BA, Brazil.
   [de Andrade Barberino, Maria Goreth] Univ Fed Bahia, Univ Hosp Prof Edgard Santos, Microbiol Lab, Salvador, BA, Brazil.
   [Cairo, Romilda Castro] FTC, Sch Med, Salvador, BA, Brazil.
   [Bandeira, Antonio Carlos; Santos, Kleber Pimentel] Med & Publ Hlth Sch Bahia, Salvador, BA, Brazil.
RP Diniz-Santos, DR (corresponding author), Av Princesa Isabel 549,Apt 11,Barra Ave, BR-40130030 Salvador, BA, Brazil.
EM dinizsantosdr@terra.com.br
CR ALICIA ADE, 1977, ESTUDIO INTEGRAL SER
   *AM HOSP ASS, 1983, FUNC PLAN LACT
   ANDRADE G P D, 1989, Revista de Saude Publica, V23, P277
   *ANVISA, 2000, CURS BAS CONTR INF H
   *BRAZ MIN HLTH, 1989, PROGR CONTR INF HOSP
   BRYAN FL, 1990, J FOOD PROTECT, V53, P978, DOI 10.4315/0362-028X-53.11.978
   Ghelardi E, 2002, FEMS MICROBIOL LETT, V208, P129, DOI 10.1111/j.1574-6968.2002.tb11072.x
   IARIA ST, 1980, REV SAUDE PUBL, V19, P93
   Pinto Uelinton Manoel, 2004, Rev. Nutr., V17, P319, DOI 10.1590/S1415-52732004000300005
   Salles Raquel Kureten De, 1997, Revista de Saude Publica, V31, P131
   SANTOS B M D O, 1989, Medicina (Ribeirao Preto), V22, P11
   TORTORA GJ, 2000, MICROBIOLOGIA
   *WHO FAO, 2004, WORKSH ENT SAK OTH M
NR 13
TC 5
Z9 5
U1 0
U2 3
PU ELSEVIER BRAZIL
PI RIO DE JANEIRO
PA R SETE SETEMBRO, 111-16, RIO DE JANEIRO, RJ 20050-006, BRAZIL
SN 1413-8670
EI 1678-4391
J9 BRAZ J INFECT DIS
JI Braz. J. Infect. Dis.
PD JUN
PY 2008
VL 12
IS 3
BP 217
EP 221
DI 10.1590/S1413-86702008000300011
PG 5
WC Infectious Diseases
SC Infectious Diseases
GA 356AP
UT WOS:000259751400011
PM 18833407
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Pedral-Sampaio, DB
   Netto, EM
   Bandeira, AC
   Guerra, C
   Barberino, MG
   Hayes, A
   Badaro, R
   Agosti, J
AF Pedral-Sampaio, DB
   Netto, EM
   Bandeira, AC
   Guerra, C
   Barberino, MG
   Hayes, A
   Badaro, R
   Agosti, J
TI Use of GM-CSF in pulmonary tuberculosis patients: preliminary results of
   a randomized clinical trial
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Meeting Abstract
C1 Univ Fed Bahia, Salvador, BA, Brazil.
   Hosp Alianca, Salvador, BA, Brazil.
   Immunex Corp, Seattle, WA USA.
   LACEN, Salvador, BA, Brazil.
RI Netto, Eduardo/D-1432-2013
OI Netto, Eduardo/0000-0003-1691-6761
NR 0
TC 0
Z9 0
U1 0
U2 0
PU UNIV CHICAGO PRESS
PI CHICAGO
PA 5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA
SN 1058-4838
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD JUL
PY 2000
VL 31
IS 1
MA 574
BP 312
EP 312
PG 1
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA 347VY
UT WOS:000088950900624
DA 2020-12-01
ER

PT J
AU Bandeira, AC
   Brites, C
   Badaro, F
   Silva, N
   Barreiro, C
   Fernandes, E
   Badaro, R
AF Bandeira, AC
   Brites, C
   Badaro, F
   Silva, N
   Barreiro, C
   Fernandes, E
   Badaro, R
TI Comparison of Poisson regression models and control charts to detect
   nosocomial outbreaks
SO INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
LA English
DT Meeting Abstract
C1 Hosp Alianca, Salvador, BA, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SLACK INC
PI THOROFARE
PA 6900 GROVE RD, THOROFARE, NJ 08086 USA
SN 0899-823X
J9 INFECT CONT HOSP EP
JI Infect. Control Hosp. Epidemiol.
PD SEP
PY 1998
VL 19
IS 9
MA S11
BP 698
EP 698
PG 1
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA 131AM
UT WOS:000076553600118
DA 2020-12-01
ER

PT J
AU Brites, C
   Netto, EM
   Bandeira, AC
   Ataide, LA
   Santos, LC
   Barberino, MG
   Badaro, R
AF Brites, C
   Netto, EM
   Bandeira, AC
   Ataide, LA
   Santos, LC
   Barberino, MG
   Badaro, R
TI Risk factors for multi-resistant Gram-negative bacilli in hospitalized
   patients in Salvador, Brazil: a case-control study
SO INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
LA English
DT Meeting Abstract
C1 Hosp Alianca, Salvador, BA, Brazil.
   Hosp Espanhol, Salvador, BA, Brazil.
   Fed Univ Hosp Bahia, Salvador, BA, Brazil.
RI Netto, Eduardo/D-1432-2013
OI Netto, Eduardo/0000-0003-1691-6761
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SLACK INC
PI THOROFARE
PA 6900 GROVE RD, THOROFARE, NJ 08086 USA
SN 0899-823X
J9 INFECT CONT HOSP EP
JI Infect. Control Hosp. Epidemiol.
PD SEP
PY 1998
VL 19
IS 9
MA M65
BP 718
EP 718
PG 1
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA 131AM
UT WOS:000076553600240
DA 2020-12-01
ER

EF